<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Respiratory muscle training for cystic fibrosis - Stanford, G - 2020 | Cochrane Library</title> <meta content="Respiratory muscle training for cystic fibrosis - Stanford, G - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006112.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Respiratory muscle training for cystic fibrosis - Stanford, G - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006112.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006112.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Respiratory muscle training for cystic fibrosis" name="citation_title"/> <meta content="Gemma Stanford" name="citation_author"/> <meta content="g.stanford16@imperial.ac.uk" name="citation_author_email"/> <meta content="Harrigan Ryan" name="citation_author"/> <meta content="Arturo Solis-Moya" name="citation_author"/> <meta content="Hospital Nacional de Niños" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD006112.pub5" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/12/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006112.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006112.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006112.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Breathing Exercises [*methods]; Cystic Fibrosis [*therapy]; Forced Expiratory Flow Rates; Inhalation [*physiology]; Quality of Life; Randomized Controlled Trials as Topic; Respiratory Muscles [*physiology]; Vital Capacity" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006112.pub5&amp;doi=10.1002/14651858.CD006112.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="uQyIsxpV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006112\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006112\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ko","ms","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006112.pub5",title:"Respiratory muscle training for cystic fibrosis",firstPublishedDate:"Dec 17, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006112.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006112.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006112.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006112.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006112.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006112.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006112.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006112.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006112.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006112.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5297 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006112.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full#CD006112-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full#CD006112-sec-0088"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full#CD006112-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full#CD006112-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full#CD006112-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full#CD006112-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full#CD006112-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full#CD006112-sec-0082"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/appendices#CD006112-sec-0093"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/supinfo/CD006112StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/supinfo/CD006112StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Respiratory muscle training for cystic fibrosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/information#CD006112-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Gemma Stanford</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/information#CD006112-cr-0005">Harrigan Ryan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006112.pub5/information#CD006112-cr-0006">Arturo Solis-Moya</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/information/en#CD006112-sec-0107">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 December 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006112.pub5">https://doi.org/10.1002/14651858.CD006112.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006112-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006112-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006112-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006112-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006112-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD006112-abs-0004">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006112-abs-0001" lang="en"> <section id="CD006112-sec-0001"> <h3 class="title" id="CD006112-sec-0001">Background</h3> <p>Cystic fibrosis is the most common autosomal recessive disease in white populations, and causes respiratory dysfunction in the majority of individuals. Numerous types of respiratory muscle training to improve respiratory function and health‐related quality of life in people with cystic fibrosis have been reported in the literature. Hence a systematic review of the literature is needed to establish the effectiveness of respiratory muscle training (either inspiratory or expiratory muscle training) on clinical outcomes in cystic fibrosis. This is an update of a previously published review. </p> </section> <section id="CD006112-sec-0002"> <h3 class="title" id="CD006112-sec-0002">Objectives</h3> <p>To determine the effectiveness of respiratory muscle training on clinical outcomes in people with cystic fibrosis. </p> </section> <section id="CD006112-sec-0003"> <h3 class="title" id="CD006112-sec-0003">Search methods</h3> <p>We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials register comprising of references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings. </p> <p>Date of most recent search: 11 June 2020.</p> <p>A hand search of the Journal of Cystic Fibrosis and Pediatric Pulmonology was performed, along with an electronic search of online trial databases. Date of most recent search: 05 October 2020. </p> </section> <section id="CD006112-sec-0004"> <h3 class="title" id="CD006112-sec-0004">Selection criteria</h3> <p>Randomised controlled studies comparing respiratory muscle training with a control group in people with cystic fibrosis. </p> </section> <section id="CD006112-sec-0005"> <h3 class="title" id="CD006112-sec-0005">Data collection and analysis</h3> <p>Review authors independently selected articles for inclusion, evaluated the methodological quality of the studies, and extracted data. Additional information was sought from trial authors where necessary. The quality of the evidence was assessed using the GRADE system. </p> </section> <section id="CD006112-sec-0006"> <h3 class="title" id="CD006112-sec-0006">Main results</h3> <p>Authors identified 20 studies, of which 10 studies with 238 participants met the review's inclusion criteria. There was wide variation in the methodological and written quality of the included studies. Four of the 10 included studies were published as abstracts only and lacked concise details, thus limiting the information available. Eight studies were parallel studies and two of a cross‐over design. Respiratory muscle training interventions varied dramatically, with frequency, intensity and duration ranging from thrice weekly to twice daily, 20% to 80% of maximal effort, and 10 to 30 minutes, respectively. Participant numbers ranged from 11 to 39 participants in the included studies; five studies were in adults only, one in children only and four in a combination of children and adults. </p> <p>No differences between treatment and control were reported in the primary outcome of pulmonary function (forced expiratory volume in one second and forced vital capacity) or postural stability (very low‐quality evidence). Although no change was reported in exercise capacity as assessed by the maximum rate of oxygen use and distance completed in a six minute walk test, a 10% improvement in exercise duration was found when working at 60% of maximal effort in one study (n = 20) (very low‐quality evidence). In a further study (n = 18), when working at 80% of maximal effort, health‐related quality of life improved in the mastery and emotion domains (very low‐quality evidence). With regards to the review's secondary outcomes, one study (n = 11) found a change in intramural pressure, functional residual capacity and maximal inspiratory pressure following training (very low‐quality evidence). Another study (n=36) reported improvements in maximal inspiratory pressure following training (P &lt; 0.001) (very low‐quality evidence). A further study (n = 22) reported that respiratory muscle endurance was longer in the training group (P &lt; 0.01). No studies reported significant differences on any other secondary outcomes. Meta‐analyses could not be performed due to a lack of consistency and insufficient detail in reported outcome measures. </p> </section> <section id="CD006112-sec-0007"> <h3 class="title" id="CD006112-sec-0007">Authors' conclusions</h3> <p>There is insufficient evidence to suggest whether this intervention is beneficial or not. Healthcare practitioners should consider the use of respiratory muscle training on a case‐by‐case basis. Further research of reputable methodological quality is needed to determine the effectiveness of respiratory muscle training in people with cystic fibrosis. Researchers should consider the following clinical outcomes in future studies; respiratory muscle function, pulmonary function, exercise capacity, hospital admissions, and health‐related quality of life. Sensory‐perceptual changes, such as respiratory effort sensation (e.g. rating of perceived breathlessness) and peripheral effort sensation (e.g. rating of perceived exertion) may also help to elucidate mechanisms underpinning the effectiveness of respiratory muscle training. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006112-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006112-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006112-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006112-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006112-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006112-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD006112-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006112-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD006112-abs-0011">Polski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006112-abs-0002" lang="en"> <h3>Training the muscles that cause the chest to expand and contract in people with cystic fibrosis </h3> <p><b>Review question</b> </p> <p>What are the effects of training muscles to influence breathing (in and out) in people with cystic fibrosis? </p> <p><b>Background</b> </p> <p>Cystic fibrosis is the most common genetic disease in white populations and causes problems with the lungs in most people with the condition. Training the muscles that cause the chest to expand and contract may help to improve lung function and the quality of life for people with cystic fibrosis. </p> <p><b>Search date</b> </p> <p>The evidence is current to: 11 June 2020.</p> <p><b>Study characteristics</b> </p> <p>We searched for studies where people with cystic fibrosis were put into either a group for respiratory muscle training or a control group at random. We included ten studies with 238 people which used a wide variety of training methods and levels. In eight of the studies, the treatment group and the control group each only received either respiratory muscle training or a control treatment (one study had three groups in total: one receiving control treatment and two receiving different levels of training). In one study the participants received both types of treatment, but in a random order. Lastly, one study compared training with usual care. The studies lasted for a maximum of 12 weeks and all were quite small; the largest only had 39 people taking part. The studies included people with a range of ages over six years old, but most seemed to be adults. The studies reported a variety of outcomes. All reported some measure of respiratory muscle strength, and most reported at least one measure of lung function, however only three studies reported on quality of life. </p> <p><b>Key results</b> </p> <p>Results could not be combined to answer the review question, because the studies either did not publish enough details or did not use the same standard measurements. No study found any difference in lung function after training, but one of the studies reported an improvement in exercise duration when training at 60% of maximal effort and a further study which trained participants at 80% of maximal effort reported some improvements in quality of life judgements. There was some evidence of an improvement in respiratory muscle function in two studies. </p> <p>Given this lack of information, a recommendation for or against respiratory muscle training cannot be made. Future studies should look to improve upon the methods of those previously conducted, and should report using standardised measurements. </p> <p><b>Quality of the evidence</b> </p> <p>It was generally unclear how people were split into groups for treatment and whether this would have affected the results. Three studies stated that the people assessing the outcomes did not know which treatment those taking part had received, but this was unclear in other studies. Individuals dropped out of three of the studies for reasons which may be directly related to the treatment and therefore may introduce a risk of bias to the results. One study had no‐one drop out and the other six studies did not state how many people dropped out of them. We assessed the quality of the evidence and judged the evidence for lung function, exercise capacity, postural stability and health‐related quality of life to be very low quality, but the evidence for respiratory muscle function to be low quality. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006112-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006112-sec-0088"></div> <h3 class="title" id="CD006112-sec-0089">Implications for practice</h3> <section id="CD006112-sec-0089"> <p>Given that there is insufficient evidence to suggest that this treatment is either beneficial or not, healthcare practitioners are advised to evaluate the use of respiratory muscle training (RMT) on a case‐by‐case basis when deciding whether or not to employ this form of exercise therapy in people with cystic fibrosis (CF). </p> </section> <h3 class="title" id="CD006112-sec-0090">Implications for research</h3> <section id="CD006112-sec-0090"> <p>Further research of reputable methodological quality is needed to determine the effectiveness of RMT in people with CF. Researchers are encouraged to consider the following clinical outcomes in future studies: </p> <p> <ul id="CD006112-list-0008"> <li> <p>respiratory muscle function (e.g. maximal inspiratory pressure (PI<sub>max</sub>)); </p> </li> <li> <p>pulmonary function (e.g. forced expiratory volume in one second (FEV<sub>1</sub>), forced vital capacity (FVC)); </p> </li> <li> <p>exercise capacity (e.g. maximum rate of oxygen consumption (VO<sub>2max</sub>)); </p> </li> <li> <p>hospital admissions;</p> </li> <li> <p>time to next exacerbation; and</p> </li> <li> <p>health‐related quality of life.</p> </li> </ul> </p> <p>Sensory‐perceptual changes, such as respiratory effort sensation (e.g. rating of perceived breathlessness) and peripheral effort sensation (e.g. rating of perceived exertion) may also help to elucidate mechanisms underpinning the effectiveness of RMT. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006112-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006112-sec-0008"></div> <div class="table" id="CD006112-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: respiratory muscle training compared with control for cystic fibrosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Respiratory muscle training compared with control for cystic fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults and children with cystic fibrosis </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> respiratory muscle training<sup>a</sup> </p> <p><b>Comparison:</b> control<sup>a</sup> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Respiratory muscle training</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FEV<sub>1</sub> % predicted</b> </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No study reported any differences between the respiratory muscle training group and the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> <p>(4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported data for FEV<sub>1</sub> % predicted at 40% of maximal capacity (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>). 2 studies reported FEV<sub>1</sub> % predicted at 30% of maximal capacity (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). 1 study reported FEV<sub>1</sub> % predicted, but did not specify the resistance used (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). </p> <p>3 studies reported FEV<sub>1</sub> measured in L and 1 measured z score; 1 study did not report the units of measurement. Results were similar to those for FEV<sub>1</sub> % predicted. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FVC: % predicted</b> </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No study reported any differences between the respiratory muscle training group and the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> <p>(3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported data for analysis for FVC (% predicted) at 40% of maximal capacity (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>) and two studies at 30% of maximal capacity (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). </p> <p>2 studies reported FVC in L and 1 measured z score; 1 study did not report the units of measurement. Results were similar to those for FVC % predicted. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exercise capacity:</b> VO<sub>2max</sub> (mL/kg/min) </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No study reported any differences between the respiratory muscle training group and the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> <p>(3 studies including 1 cross‐over study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One study with an unspecified level of resistance reported an improvement within the respiratory muscle training group. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HRQoL:</b> total score </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>2 studies reported no differences between the respiratory muscle training group and the control group. </p> <p>1 study reported improvements in the parameters of mastery and emotion in the respiratory muscle training group compared to the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> <p>(3 studies including 1 cross‐over study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 studies used the Chronic Respiratory Disease Questionnaire (CRDQ) and 1 study used the cystic fibrosis questionnaire (CFQ). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Respiratory muscle function:</b> maximal inspiratory pressure (PI<sub>max</sub>) </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>There was a greater improvement in the respiratory muscle training groups in 2 of the 4 studies measuring this outcome: MD 26.00 (95% CI 8.63 to 43.47) (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>); and MD 14.63 (95% CI 5.63 to 23.63) (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). </p> <p>The remaining 2 studies reported no differences between the respiratory muscle training group and the control group (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> <p>(4 studies including 1 cross‐over study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Of the studies reporting a difference, the Sawyer study measured at 60% of maximal effort (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>) and the Zeren study measured at 30% resistance (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). </p> <p>1 of the remaining studies reported at 30% of maximal effort (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>) and 1 did not specify the level of resistance (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Respiratory muscle function</b>: inspiratory capacity </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>FEV<sub>1</sub> </b> : forced expiratory volume in 1 second; <b>FVC</b> : forced vital capacity; <b>HRQoL</b> : health related quality of life; <b>NA</b> : not applicable; <b>VO₂<sub>max</sub> </b> : maximal oxygen uptake. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>a. The resistance level of the respiratory muscle training intervention was variable; three studies used 80% of maximal effort, one study used 60% of maximal effort, one study used 40% of maximal effort, one study used 30% of maximal effort and three studies did not specify the level of resistance. Control groups were also variable; cycle ergometer, H<sub>2</sub>0, treatment as usual, standard chest physiotherapy, low resistance threshold loading device, no training or sham training. </p> <p>b. Downgraded twice due to serious risk of bias: the included studies lacked methodological detail relating to methods of randomisation, allocation concealment and blinding. Most of the studies were at high risk of bias due to lack of blinding, incomplete outcome data or selective reporting, or both. </p> <p>c. Downgraded due to imprecision: studies included a small number of participants and numerical results were not available for some of the studies. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006112-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006112-sec-0009"></div> <section id="CD006112-sec-0010"> <h3 class="title" id="CD006112-sec-0010">Description of the condition</h3> <p>Cystic Fibrosis (CF) is caused by mutations of the CF transmembrane conductance regulator (CFTR) gene that disturbs the function of the CFTR channel (<a href="./references#CD006112-bbs2-0034" title="ElbornJS . Cystic Fibrosis. The Lancet2016;388(10059):2519-31.">Elborn 2016</a>). Over 2000 variants of CFTR mutations with a spectrum of effects on CFTR function, have been identified to date (<a href="./references#CD006112-bbs2-0025" title="BellSC , MallMA , GutierrezH , MacekM , MadgeS , DaviesJC , et al. The future of cystic fibrosis care: a global perspective. The Lancet Respiratory Medicine2020;8(1):65-124.">Bell 2020</a>). Dysfunction of the CFTR channel reduces chloride secretion resulting in dehydrated and viscous secretions that are difficult to clear (<a href="./references#CD006112-bbs2-0057" title="WineJJ . The genesis of cystic fibrosis lung disease. Journal of Clinical Investigation1999;103(3):309-12.">Wine 1999</a>). The pathological consequences of this mutation can impact function of the respiratory, reproductive and digestive systems, as well as affecting temperature regulation and fluid balance (<a href="./references#CD006112-bbs2-0055" title="WheatleyCM , WilkinsBW , SnyderEM . Exercise is medicine in cystic fibrosis. Exercise and Sport Sciences Reviews2011;39(3):155-60.">Wheatley 2011</a>). At present the median predicted survival stands at 49.1 years in the UK and 44 years in the USA (<a href="./references#CD006112-bbs2-0028" title="Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2019 Annual Data Report. www.cff.org/Research/Researcher-Resources/Patient-Registry/2019-Patient-Registry-Annual-Data-Report.pdf (accessed 16 December 2020).">CFF 2019</a>; <a href="./references#CD006112-bbs2-0053" title="Cystic Fibrosis Trust. UK Cystic Fibrosis Registry Annual Data Report 2019. www.cysticfibrosis.org.uk/the-work-we-do/uk-cf-registry/reporting-and-resources (accessed 16 December 2020).">UK CF Trust  2019</a>). Recently the management of CF has changed dramatically with the introduction of CFTR modulator medications, which correct the basic defect (<a href="./references#CD006112-bbs2-0025" title="BellSC , MallMA , GutierrezH , MacekM , MadgeS , DaviesJC , et al. The future of cystic fibrosis care: a global perspective. The Lancet Respiratory Medicine2020;8(1):65-124.">Bell 2020</a>), which in time may alter the presentation and complications of CF. However a large proportion of today’s CF population still have significant CF manifestations which cause morbidity and premature mortality. </p> <p>Worldwide, respiratory or cardiorespiratory causes are the current primary cause of death from CF (<a href="./references#CD006112-bbs2-0028" title="Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2019 Annual Data Report. www.cff.org/Research/Researcher-Resources/Patient-Registry/2019-Patient-Registry-Annual-Data-Report.pdf (accessed 16 December 2020).">CFF 2019</a>; <a href="./references#CD006112-bbs2-0053" title="Cystic Fibrosis Trust. UK Cystic Fibrosis Registry Annual Data Report 2019. www.cysticfibrosis.org.uk/the-work-we-do/uk-cf-registry/reporting-and-resources (accessed 16 December 2020).">UK CF Trust  2019</a>),  accounting for 70.2% of all UK deaths from CF between 2017 and 2019 (<a href="./references#CD006112-bbs2-0053" title="Cystic Fibrosis Trust. UK Cystic Fibrosis Registry Annual Data Report 2019. www.cysticfibrosis.org.uk/the-work-we-do/uk-cf-registry/reporting-and-resources (accessed 16 December 2020).">UK CF Trust  2019</a>). CFTR dysfunction creating viscous secretions leads to bacterial colonisation and chronic pulmonary infection which imposes structural lung damage, mostly bronchiectasis, and small airway obstruction (<a href="./references#CD006112-bbs2-0027" title="CantinAM , HartlD , KonstanMW , ChmielJF . Inflammation in cystic fibrosis lung disease: pathogensis and therapy. Journal of Cystic Fibrosis2015;14(4):419-30.">Cantin 2015</a>). Recurrent pulmonary infection results in the progressive deterioration of pulmonary function and eventually respiratory failure (<a href="./references#CD006112-bbs2-0037" title="GrasemannH , RatjenF . Early lung disease in cystic fibrosis. The Lancet2013;1(2):148-57.">Grasemann 2013</a>). Other physiological factors such as inflammation, gas trapping and mucous plugging contribute towards further airway obstruction, thus reducing forced expiratory volumes and causing excessive dyspnoea (<a href="./references#CD006112-bbs2-0040" title="KozlowskaWJ , BushA , WadeA , AuroraP , CarrSB , CastleRA , et al. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. American Journal of Respiratory and Critical Care Medicine2008;178(1):42-9.">Kozlowska 2008</a>). Co‐morbidities such as thoracic kyphosis can exacerbate this, restricting lung expansion, decreasing lung volumes, and leading to an increased work of breathing (<a href="./references#CD006112-bbs2-0024" title="ArisRM , RennerJB , WindersAD , BuellHE , RiggsDB , LesterGE , et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Annals of Internal Medicine1998;128(3):186-93.">Aris 1998</a>; <a href="./references#CD006112-bbs2-0032" title="DentonJR , TietjenR , GaerlanPF . Thoracic kyphosis in cystic fibrosis. Clinical Orthopaedics and Related Research1981;155:71-4.">Denton 1981</a>). </p> <p>Management of CF has evolved around preventing infections and deterioration of pulmonary function through individualised combinations of medications including antibiotics and mucoactive agents alongside airway clearance to optimise secretion mobilisation. This management strategy has led to a substantial increase in life expectancy for people with CF over the last 30 years (<a href="./references#CD006112-bbs2-0044" title="RatjenF , BellSC , RoweSM , GossCH , QuittnerAL , BushA . Cystic fibrosis. Nature Reviews Disease Primer2015;1(1):15010. [DOI: 10.1038/nrdp.2015.10]">Ratjen 2015</a>). With an increasingly well population, interventions such as exercise which focus on optimising health outcomes and preventing complications of CF are becoming key in CF care. </p> </section> <section id="CD006112-sec-0011"> <h3 class="title" id="CD006112-sec-0011">Description of the intervention</h3> <p>Respiratory muscle training (RMT) is a form of exercise training specifically targeting the muscles that drive expansion or contraction of the chest, or both. Training can stress the musculature of inspiration or expiration, or both, depending upon the type of training performed and the specification of the individual device. There are two main types of RMT, namely resistive training and normocapnic hyperpnoea. Resistive training can be performed using either flow‐resistive loading or pressure‐threshold loading, and requires the use of a portable hand‐held device. Both devices typically involve a one‐way valve mechanism, such that only the inspiratory or expiratory musculature can be trained at one given time. Flow‐resistive loading involves breathing through a hole of small diameter (resistor), thus limiting airflow, increasing the work of breathing and challenging the respiratory musculature. The resistance (load) applied to the respiratory musculature can be adjusted according to the diameter of the hole, whereby reducing the diameter increases airflow limitation. Pressure‐threshold training creates a similar physiological challenge, and involves breathing with sufficient force to overcome a spring‐loaded valve to enable airflow. The resistance (load) is set at a proportion of maximal static inspiratory mouth pressure (PI<sub>max</sub>). Resistive training regimens vary in terms of the intensity (load), duration (sets, repetitions and time) and frequency (sessions per week), depending upon the desired physiological outcome i.e. muscular strength or endurance. Overall training volume can be altered using a combination of intensity, duration and frequency, and training can be either continuous or interval in nature. While resistive training can be performed under the supervision of a suitably qualified therapist, users may perform this independently. </p> <p>Normocapnic hyperpnoea is a type of RMT that requires the individual to ventilate at a high proportion of their maximum voluntary ventilation (MVV) for a predetermined period of time (around 10 to 15 minutes (<a href="./references#CD006112-bbs2-0039" title="KoppersRJH , VosPJE , Folgering HthM. Tube breathing as a new potential method to perform respiratory muscle training: Safety in healthy volunteers. Respiratory Medicine2006;100:714-720.">Koppers 2006</a>)). It is proposed that normocapnic hyperpnoea strengthens the respiratory muscles by accelerated deep breathing with controlled oxygen saturation of the blood. Complex rebreathing circuitry is required to perform this form of training and to minimise the risk of inducing hypercapnia. Unlike resistive training, normocapnic hyperpnoea trains both the inspiratory and expiratory musculature simultaneously. As the physiological challenge is derived from high ventilation, as opposed to high resistive load, the training load is determined by the rate of minute ventilation. For the same reason, normocapnic hyperpnoea is thought to target muscular endurance as opposed to muscular strength (<a href="./references#CD006112-bbs2-0045" title="ReidWD , Samrai B. Respiratory muscle training for patients with chronic obstructive pulmonary disease. Physical Therapy1995;75(11):996-1005.">Reid 1995</a>). </p> </section> <section id="CD006112-sec-0012"> <h3 class="title" id="CD006112-sec-0012">How the intervention might work</h3> <p>It has been suggested that RMT may improve health‐related quality of life, pulmonary function and exercise capacity in people with CF (<a href="./references#CD006112-bbs2-0042" title="PadulaCA , YeawE . Inspiratory muscle training: integrative review of use in conditions other than COPD. Research and Theory for Nursing Practice2007;21(2):98-118.">Padula 2007</a>). Some studies have postulated that RMT may enhance the clearance of mucous from the lungs (<a href="./references#CD006112-bbs2-0029" title="ChathamK , IonescuAA , NixonLS , ShaleDJ . A short-term comparison of two methods of sputum expectoration in cystic fibrosis. European Respiratory Journal2004;23(3):435-9.">Chatham 2004</a>), which is a fundamental aspect in preventing pulmonary infection. Although RMT may be thought to improve pulmonary function, exercise tolerance and quality of life, the causal mechanisms remain unclear. </p> <p>As there is some evidence that people with CF have similar respiratory muscle strength to healthy peers (<a href="./references#CD006112-bbs2-0023" title="ArikanH , Yatar İ, Calik-KutukcuE , AribasZ , SaglamM , Vardar-YagliN , et al. A comparison of respiratory and peripheral muscle strength, functional exercise capacity, activities of daily living and physical fitness in patients with cystic fibrosis and healthy subjects. Research in Developmental Disabilities2015;45-6:147-56. [DOI: 10.1016/j.ridd.2015.07.020]">Arikan 2015</a>; <a href="./references#CD006112-bbs2-0033" title="DunninkMA , DoelemanWR , TrappenburgJCA , deVriesWR . Respiratory muscle strength in stable adolescent and adult patients with cystic fibrosis. Journal of Cystic Fibrosis2009;8(1):31-6.">Dunnink 2009</a>), several potential mechanisms that have been postulated in a healthy population may also be comparable in those with CF. Perceptual changes have been found to occur following RMT, whereby a significant reduction in the perception of respiratory effort has been observed (<a href="./references#CD006112-bbs2-0048" title="RomerLE , McConnellAK , JonesDD . Effects of inspiratory muscle training on time-trial performance in trained cyclists. Journal of Sports Sciences2002;29(97):547-62.">Romer 2002</a>). Numerous mechanisms have been hypothesised, including an improvement in the contractile and endurance  properties of the inspiratory musculature, and a desensitising effect on the sensory input from the inspiratory muscles to the brain (<a href="./references#CD006112-bbs2-0036" title="El-ManshawiA , KillianKJ , SummersE , JonesN . Breathlessness during exercise with and without resistive loading. Journal of Applied Physiology1986;61(3):896-905.">El‐Manshawi 1986</a>; <a href="./references#CD006112-bbs2-0046" title="ReveletteWR , WileyRL . Plasticity of the mechanism subserving inspiratory load perception. Journal of Applied Physiology1987;62(5):1901-6.">Revelette 1987</a>; <a href="./references#CD006112-bbs2-0049" title="SalesAT , FregoneziGA , RamsookAH , GuenetteJA , LimaIN , ReidWD . Respiratory muscle endurance after training in athletes and non-athletes: a systematic review and meta-analysis. Physical Therapy in Sport2016;17:76-86. [DOI: 10.1016/j.ptsp.2015.08.001]">Sales 2016</a>; <a href="./references#CD006112-bbs2-0056" title="WilsonRC , JonesPW . Influence of prior ventilatory experience on the estimation of breathlessness during exercise. Clinical Science1990;78(2):149-53.">Wilson 1990</a>). Significant reductions in the perception of peripheral effort have also been observed, attributed to a changes in acid‐base balance and respiratory muscle blood flow (<a href="./references#CD006112-bbs2-0026" title="CaineMP , McConnellAK . Development and evaluation of a pressure threshold inspiratory muscle trainer for use in the context of sports performance. Sports Engineering2000;3(3):149-59.">Caine 2000</a>). Reduced work of breathing and decreased rating of perceived breathlessness or exertion have also been reported (<a href="./references#CD006112-bbs2-0052" title="SheiRJ . Recent advancements in our understanding of the ergogenic effect of respiratory muscle training in healthy humans: a systematic review. Journal of Strength and Conditioning Research2018;32(9):2665-76. [DOI: 10.1519/JSC.0000000000002730]">Shei 2018</a>). </p> <p>In CF, these mechanisms may also account for the improvements in health‐related quality of life, pulmonary function and exercise capacity that have been observed. As a combination of structural lung damage and physical deconditioning can increase the perception of respiratory (dyspnoea) and peripheral effort in people with CF, the need for this review is apparent. </p> </section> <section id="CD006112-sec-0013"> <h3 class="title" id="CD006112-sec-0013">Why it is important to do this review</h3> <p>Prior to the original version of this review (<a href="./references#CD006112-bbs2-0059" title="HoustonBW , van derSchansCP . Inspiratory muscle training for cystic fibrosis. Cochrane Database of Systematic Reviews2008, Issue 4. Art. No: CD006112. [DOI: 10.1002/14651858.CD006112]">Houston 2008</a>), there was no systematic review of the currently available evidence from randomised controlled trials (RCTs) or quasi‐randomised controlled trials as to whether RMT is beneficial, nor on the optimal regime (i.e. the nature of the training load and specifics of the training protocol), for people with CF. The effect of RMT on improving health outcomes in CF remains unclear. Previous versions of this Cochrane Review were unable to conclude if this treatment is either beneficial or not, due to the apparent lack of clinical trials, particularly those of a high‐quality; this version of the review is the latest update of the original review (<a href="./references#CD006112-bbs2-0058" title="HiltonN , Solis‐MoyaA . Respiratory muscle training for cystic fibrosis. Cochrane Database of Systematic Reviews2018, Issue 5. Art. No: CD006112. [DOI: 10.1002/14651858.CD006112.pub4]">Hilton 2018</a>; <a href="./references#CD006112-bbs2-0059" title="HoustonBW , van derSchansCP . Inspiratory muscle training for cystic fibrosis. Cochrane Database of Systematic Reviews2008, Issue 4. Art. No: CD006112. [DOI: 10.1002/14651858.CD006112]">Houston 2008</a>; <a href="./references#CD006112-bbs2-0060" title="HoustonBW , MillsN , Solis-MoyaA . Inspiratory muscle training for cystic fibrosis. Cochrane Database of Systematic Reviews2009, Issue 3. Art. No: CD006112. [DOI: 10.1002/14651858.CD006112.pub2]">Houston 2009</a>; <a href="./references#CD006112-bbs2-0061" title="HoustonBW , MillsN , Solis-MoyaA . Inspiratory muscle training for cystic fibrosis. Cochrane Database of Systematic Reviews2013, Issue 11. Art. No: CD006112. [DOI: 10.1002/14651858.CD006112.pub3]">Houston 2013</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006112-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006112-sec-0014"></div> <p>To determine the effectiveness of respiratory muscle training on clinical outcomes in people with cystic fibrosis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006112-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006112-sec-0015"></div> <section id="CD006112-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006112-sec-0017"> <h4 class="title">Types of studies</h4> <p>Any parallel or cross‐over randomised controlled trial (RCT) comparing RMT with a control group. </p> </section> <section id="CD006112-sec-0018"> <h4 class="title">Types of participants</h4> <p>Any person with CF who has been diagnosed by sweat testing, genotyping or both. Participants were included irrespective of gender, age, or the presence of co‐morbidities. </p> </section> <section id="CD006112-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Trials were considered for inclusion if the author(s) had compared RMT with a control group, such as a placebo (e.g. sham‐training) or no intervention. RMT included either inspiratory or expiratory muscle training, or both, including resistive loading (flow‐resistive or pressure threshold, or both) and normocapnic hyperpnoea training. Singing training interventions were excluded from this review. Studies that performed RMT in combination with any other form of physical exercise training were excluded from the review. Combining these interventions is the subject of another Cochrane Review (<a href="./references#CD006112-bbs2-0043" title="RadtkeT , NolanSJ , HebestreitH , KriemlerS . Physical exercise training for cystic fibrosis. Cochrane Database of Systematic Reviews2017, Issue 11. Art. No: CD002768. [DOI: 10.1002/14651858.CD002768.pub4]">Radtke 2015</a>). </p> </section> <section id="CD006112-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We assessed the following outcome measures.</p> <section id="CD006112-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD006112-list-0001"> <li> <p>Pulmonary function</p> <ol id="CD006112-list-0002"> <li> <p>forced expiratory volume at one second (FEV<sub>1</sub>) </p> </li> <li> <p>forced vital capacity (FVC)</p> </li> <li> <p>peak expiratory flow (PEF)</p> </li> </ol> </li> <li> <p>Exercise capacity (measured by e.g. maximal oxygen uptake (VO<sub>2max</sub>), exercise duration, etc.) </p> </li> <li> <p>Health‐related quality of life (measured by e.g. Chronic Respiratory Disease Questionnaire (CRDQ) (<a href="./references#CD006112-bbs2-0030" title="ChauvinA , RupleyL , MeyersK , JohnsonK , EasonJ . Outcomes in Cardiopulmonary Physical Therapy: Chronic Respiratory Disease Questionnaire (CRQ). Cardiopulmonary Physical Therapy Journal2008;19(2):61-7.">Chauvin 2008</a>), Cystic Fibrosis Questionnaire (CFQ) (<a href="./references#CD006112-bbs2-0054" title="WenningerK , AussageP , WahnU , StaabD . The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument. Quality of Life Research2003;12:77–85.">Wenninger 2003</a>), etc.) </p> </li> </ol> </p> </section> <section id="CD006112-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD006112-list-0003"> <li> <p>Respiratory muscle function</p> <ol id="CD006112-list-0004"> <li> <p>maximal inspiratory pressure (PI<sub>max</sub>) </p> </li> <li> <p>inspiratory capacity (IC)</p> </li> <li> <p>maximal expiratory pressure (PE<sub>max</sub>) </p> </li> </ol> </li> <li> <p>Respiratory muscle strength and endurance (RME)</p> </li> <li> <p>Frequency and duration of respiratory infections, hospitalisations</p> </li> <li> <p>Adherence</p> </li> <li> <p>Death or survival</p> </li> <li> <p>Adverse effects (pneumothorax, musculoskeletal pains or injuries, others)</p> </li> <li> <p>Costs</p> </li> <li> <p>Oxygen saturations (post hoc change)</p> </li> <li> <p>Postural stability measured using the Biodex Balance System (post hoc change)</p> </li> </ol> </p> </section> </section> </section> <section id="CD006112-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>The authors searched for all relevant published and unpublished trials without restrictions on language, year or publication status. </p> <section id="CD006112-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We identified relevant studies from the Group's Cystic Fibrosis Trials Register using the term: inspiratory muscle training.<br/><br/>The Group's Cystic Fibrosis Trials Register, which is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (updated each new issue of <i>The Cochrane Library</i> ), weekly searches of MEDLINE, a search of Embase to 1995 and the prospective handsearching of two journals ‐ <i>Pediatric Pulmonology</i> and the <i>Journal of Cystic Fibrosis</i>. Unpublished work is identified by searching the abstract books of four major cystic fibrosis conferences: the International Cystic Fibrosis Conference; the European Cystic Fibrosis Conference, the North American Cystic Fibrosis Conference and the Australia and New Zealand Cystic Fibrosis Conference. For full details of all searching activities for the register, please see the relevant sections of the Cystic Fibrosis and Genetic Disorders Group <a href="http://cfgd.cochrane.org/our-specialised-trials-registers" target="_blank">website</a>. </p> <p>Date of the last search of the Group's Cystic Fibrosis Trials Register: 11 June 2020.</p> <p>We also performed separate searches of clinicaltrials.gov and the WHO ICTRP databases (<a href="./appendices#CD006112-sec-0094">Appendix 1</a>; <a href="./appendices#CD006112-sec-0095">Appendix 2</a>). Date of the last search: 05 October 2020. </p> <p>We completed separate searches of the following databases: MEDLINE, PEDro (The Physiotherapy Evidence Database), Science Direct and SCOPUS between July and October 2020 (for the individual dates please see the relevant appendix), using both the Cochrane RCT and CF search filters and terms specific to the intervention (<a href="./appendices#CD006112-sec-0096">Appendix 3</a>; <a href="./appendices#CD006112-sec-0097">Appendix 4</a>; <a href="./appendices#CD006112-sec-0098">Appendix 5</a>; <a href="./appendices#CD006112-sec-0099">Appendix 6</a>). </p> <p>For versions of the review up to and including 2014 the former author team also performed separate searches of the following databases: Embase, CINAHL, AMED (Allied and Complementary Medicine), BIOSIS Previews to 2013, using both the Cochrane RCT and Cystic Fibrosis search filters; and terms specific to the intervention (<a href="./appendices#CD006112-sec-0096">Appendix 3</a>; <a href="./appendices#CD006112-sec-0097">Appendix 4</a>; <a href="./appendices#CD006112-sec-0098">Appendix 5</a>; <a href="./appendices#CD006112-sec-0099">Appendix 6</a>). They also searched <a href="http://www.controlled-trials.com/" target="_blank">Current Controlled Trials</a> and the <a href="http://www.update-software.com/national/" target="_blank">UK National Research Register</a>for ongoing and recently completed studies. These searches last run on the 01 August 2013 (<a href="./appendices#CD006112-sec-0098">Appendix 5</a>; <a href="./appendices#CD006112-sec-0099">Appendix 6</a>; <a href="./appendices#CD006112-sec-0100">Appendix 7</a>). </p> </section> <section id="CD006112-sec-0025"> <h4 class="title">Searching other resources</h4> <p>For this update and the original review, we also contacted manufacturers and study investigators and checked reference lists of relevant literature. </p> </section> </section> <section id="CD006112-sec-0026"> <h3 class="title" id="CD006112-sec-0026">Data collection and analysis</h3> <p>Where the text below describes "the authors", up to the 2018 update the original three authors (BH, NM and ASM) are referred to; for the 2018 update "the authors" refers to NH and ASM and for the 2020 update "the authors" refers to GS, ASM and HR.  </p> <section id="CD006112-sec-0027"> <h4 class="title">Selection of studies</h4> <p>To identify potentially eligible studies, authors screened the titles and abstracts of each record retrieved from the search. We then obtained the full‐text articles and inspected these independently for the review, including titles and abstracts that could not be rejected with certainty. If we could not reach an agreement we would have resolved these issues by discussion and the involvement of another person if necessary. </p> </section> <section id="CD006112-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>The review authors assessed the methodological quality of the selected studies and independently extracted data using a standardised data collection form based upon the recommendation in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006112-bbs2-0041" title="LiT , HigginsJP , Deeks JJ (editors). Chapter 5: Collecting data. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Li 2020</a>). We entered all eligible studies into the Review Manager software (<a href="./references#CD006112-bbs2-0047" title="Review Manager Web (RevMan Web). Version 1.22. The Cochrane Collaboration, 2020. Available at revman.cochrane.org.">RevMan Web 2020</a>); we did not need to resolve any disagreements. </p> <p>The data will be grouped at the following time points: up to one month; one month to three months; three to six months; six months to one year and annually thereafter.  </p> </section> <section id="CD006112-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The review authors used the Cochrane risk of bias tool to independently assess the study quality according to the following criteria: sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and any other identified sources of bias (<a href="./references#CD006112-bbs2-0038" title="Higgins JP , Altman DG , Sterne JA, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook.">Higgins 2017</a>). We also considered the external validity of each study, particularly the description of study participants (e.g. mean FEV<sub>1</sub>) and the study intervention (e.g. controlling inspiratory flow rate), as well as the reliability of reported outcomes (e.g. familiarity). </p> </section> <section id="CD006112-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>The review authors graphically presented quantitative data for the outcomes listed in the inclusion criteria. Where we were able to obtain data for continuous outcomes (pulmonary function, exercise capacity, quality of life, respiratory muscle function, frequency and duration of respiratory infections, hospitalisations and costs), we calculated the mean differences (MD) and presented these with 95% confidence intervals (CIs). No analysable data were available for dichotomous outcomes; for future updates, if we are able to analyse dichotomous outcomes (adherence, survival and adverse effects), we plan to calculate the risk ratio (RR) and 95% CIs for dichotomous outcomes. </p> </section> <section id="CD006112-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>Ideally when conducting a meta‐analysis combining results from cross‐over studies, the review authors planned to use the inverse variance methods that are recommended by Elbourne (<a href="./references#CD006112-bbs2-0035" title="ElbourneDR , AltmanDG , HigginsJPT , CurtinF , WorthingtonHV , VailA . Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology2002;31(1):140-9.">Elbourne 2002</a>). However, if there were limited data available they planned to either use first‐arm data only or treat the cross‐over study as if it was of parallel design (assuming a correlation of zero as the most conservative estimate). Elbourne says that this approach produces conservative results as it does not take into account within‐patient correlation (<a href="./references#CD006112-bbs2-0035" title="ElbourneDR , AltmanDG , HigginsJPT , CurtinF , WorthingtonHV , VailA . Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology2002;31(1):140-9.">Elbourne 2002</a>). Also each participant appears in both the treatment and control group, so the two groups are not independent. Currently there are two cross‐over studies included in the review and we have reported the results narratively due to data limitations (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). </p> <p>Where studies measured data longitudinally, the authors based the analysis on the results from the final time point. Methods are not yet available to carry out a meta‐analysis of aggregate longitudinal data, where individual patient data (IPD) is not available. </p> </section> <section id="CD006112-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>Where data were missing, the review authors attempted to contact the author(s) of the study to obtain the missing data. Where data are still missing, we catagorised these studies as 'awaiting classification'. We only analysed the available data (i.e. without imputing missing data). </p> </section> <section id="CD006112-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We would have conducted a meta‐analysis and assessed heterogeneity if we had included and combined sufficient studies in the review. We planned to examine heterogeneity between comparable studies using a standard Chi² test with the alpha level of significance set at P &lt; 0.05. We would have determined levels of heterogeneity using the I² statistic, whereby we considered I² greater than 50% to be substantial heterogeneity (<a href="./references#CD006112-bbs2-0031" title="DeeksJJ , HigginsJP , Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated October 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook..">Deeks 2020</a>). </p> </section> <section id="CD006112-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>If sufficient data were available, the review authors planned to explore potential publication bias by preparing a funnel plot. Where possible the authors compared the 'Methods' section of the full study report to the outcomes reported in the 'Results' section to identify any selective outcome reporting. </p> </section> <section id="CD006112-sec-0035"> <h4 class="title">Data synthesis</h4> <p>The review authors planned to pool the results of comparable groups of studies using the fixed‐effect model and to calculate the relevant 95% CIs if sufficient data were available. </p> </section> <section id="CD006112-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>The review authors did not plan to perform any meta‐analyses if there had been substantial and statistically significant heterogeneity. If we had been able to combine a sufficient number of included studies and had identified substantial heterogeneity (as defined above), we planned to explore this using the following subgroup analyses: </p> <p> <ol id="CD006112-list-0005"> <li> <p>type of RMT (e.g. resistive loading or normocapnic hypopnea)</p> </li> <li> <p>regimen of RMT (e.g. daily versus three times per week)</p> </li> <li> <p>characteristics of study participants</p> <ol id="CD006112-list-0006"> <li> <p>age (up to 16 years versus older than 16 years)</p> </li> <li> <p>gender</p> </li> <li> <p>participants with poor respiratory muscle strength compared to those with preserved strength (e.g. determined by PI<sub>max</sub>) </p> </li> <li> <p>participants with mild airflow obstruction compared to those with severe hyperinflation airflow obstruction (e.g. determined by FEV<sub>1</sub>) </p> </li> </ol> </li> <li> <p>definition of outcome measures</p> </li> </ol> </p> </section> <section id="CD006112-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>If we had been able to include and combine a sufficient number of studies, we would have performed sensitivity analyses based upon the methodological quality of the included studies, including allocation concealment, blinding of outcome assessments, and analyses performed on an intention‐to‐treat basis. </p> </section> <section id="CD006112-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>In a post hoc change at the 2018 update, and in accordance with current Cochrane guidance, we have included a summary of findings table presenting results comparing respiratory muscle training (all intensities) versus control comparison. We have included the six outcomes which we consider to be the most clinically relevant. </p> <p> <ul id="CD006112-list-0007"> <li> <p>FEV<sub>1</sub> % predicted </p> </li> <li> <p>FVC % predicted</p> </li> <li> <p>VO<sub>2max</sub> (mL/kg/min) </p> </li> <li> <p>health‐related quality of life (overall score)</p> </li> <li> <p>PI<sub>max</sub> </p> </li> <li> <p>IC</p> </li> </ul> </p> <p>We assessed the quality of the evidence for each outcome using the GRADE approach (<a href="./references#CD006112-bbs2-0050" title="SchünemannHJ , VistGE , HigginsJP , SantessoN , DeeksJJ , GlasziouP , et al. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Schünemann 2020a</a>; <a href="./references#CD006112-bbs2-0051" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Schünemann 2020b</a>). This approach is based on the risk of bias within the studies, relevance to our population of interest (indirectness), unexplained heterogeneity or inconsistency, imprecision of the results or high risk of publication bias. We downgraded the evidence once if the risk was serious and twice if the risk was deemed to be very serious. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006112-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006112-sec-0039"></div> <section id="CD006112-sec-0040"> <h3 class="title">Description of studies</h3> <p>Please see the tables for additional information (<a href="./references#CD006112-sec-0116" title="">Characteristics of included studies</a>; <a href="./references#CD006112-sec-0117" title="">Characteristics of excluded studies</a>; <a href="./references#CD006112-sec-0118" title="">Characteristics of studies awaiting classification</a>). </p> <section id="CD006112-sec-0041"> <h4 class="title">Results of the search</h4> <p>The database searches identified 279 potentially eligible studies. The authors reviewed the abstracts of the studies and identified 10 studies with a total of 238 participants for inclusion (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). Of these 10 studies, four were published as abstracts only (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>). A further seven studies were excluded (<a href="./references#CD006112-bbs2-0011" title="HowardJ , BradleyJ , HewittO , ElbornS . The active cycle of breathing (ACBT) is a more effective method of airway clearance in cystic fibrosis (CF) patients than the test of incremental respiratory endurance (TIRE). Pediatric Pulomonology2000;30 Suppl 20:304. [ABSTRACT NO.: 457] [CFGD REGISTER: PE116] ">Howard 2000</a>; <a href="./references#CD006112-bbs2-0012" title="IronsJY , KennyD , ChangAB . Let's sing out!: The effect of singing on quality of life and lung function of children and adolescents with cystic fibrosis. Www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ID=839442009. [CFGD REGISTER: PE185a ] 5500100000010548 IronsJY , KennyDT , McElreaM , ChangAB . Singing therapy for young people with cystic fibrosis: a randomized controlled pilot study. Music and Medicine2012;4(3):136-45. [CFGD REGISTER: PE185b ] 5500100000007892 ">Irons 2012</a>; <a href="./references#CD006112-bbs2-0013" title="KeensTG , KrastinsIRB , WannamakerE , LevisonH , CrozierDN , BryanAC . Ventilatory muscle endurance training in normal subjects and patients with cystic fibrosis. American Review of Respiratory Disease1977;116(5):853-60. ">Keens 1977</a>; <a href="./references#CD006112-bbs2-0014" title="PattersonJE , BradleyJM . Inspiratory muscle training in adult patients with cystic fibrosis: a randomised controlled trial to evaluate the efficacy of the test of incremental respiratory endurance (TIRE). Thorax2004;59(Suppl II):ii13. [ABSTRACT NO: S36] [CENTRAL: 518434] [CFGD REGISTER: PE236] ">Patterson 2004</a>; <a href="./references#CD006112-bbs2-0015" title="Santana-SosaE , Gonzalez-SaizL , GroeneveldIF , Villa-AsensiJR , Barrio Gomez de AgueroMI , FleckSJ , et al. Benefits of combining inspiratory muscle with 'whole muscle' training in children with cystic fibrosis: a randomised controlled trial. British Journal of Sports Medicine2014;48(20):1513-7. [CENTRAL: CN-00874806] [CFGD REGISTER: PE201] [PMID: 23681502]">Santana‐Sosa 2014</a>; <a href="./references#CD006112-bbs2-0016" title="SartoriR , BarbiE , PoliF , RonfaniL , MarchettiF , AmaddeO , et al. Respiratory training with a specific device in cystic fibrosis: a prospective study. Journal of Cystic Fibrosis2008;7(4):313-9. ">Sartori 2008</a>; <a href="./references#CD006112-bbs2-0017" title="VivodtzevI , DecorteN , WuyamB , GonnetN , DurieuI , LevyP , et al. Benefits of neuromuscular electrical stimulation prior to endurance training in patients with cystic fibrosis and severe pulmonary dysfunction. Chest2013;143(2):485-93. ">Vivodtzev 2013</a>). Five studies are currently listed as 'Awaiting classification' until further details are available (<a href="./references#CD006112-bbs2-0018" title="EmirzaC , AslanGK , KilincAA , CokugrasHC . Effect of expiratory muscle training on peak cough flow in children and adolescents with cystic fibrosis. erscongress.org/images/congress-2020/programme/detailedprogramme/ExportFinalProgram_31082020021051.pdf (accessed 15 October 2020):198. [ABSTRACT NO.: 2968] NCT03873688. Effects of expiratory muscle training on cough efficacy in children and adolescents with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03873688 (first posted 13 March 2019). ">Emirza 2020</a>; <a href="./references#CD006112-bbs2-0019" title="GiacomodonatoB , GrazianoL , CurziM , PerelliT , De SanctisS , VarchettaM , et al. Respiratory muscle endurance training with normocapnic hyperpnea in patients with cystic fibrosis. A randomized controlled study. Journal of Cystic Fibrosis2015;14 Suppl 1:S41. [ABSTRACT NO.: WS21.10] [CFGD REGISTER: PE217] ">Giacomodonato 2015</a>; <a href="./references#CD006112-bbs2-0020" title="NCT03190031. Respiratory muscle training in CF patients (MUCOMUREE) [Respiratory muscle training in patients with cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03190031 (first posted 16 June 2017). ">NCT03190031</a>; <a href="./references#CD006112-bbs2-0021" title="NCT03737630. Inspiratory muscle training in individuals with cystic fibrosis [Effects of inspiratory muscle training in individuals who have cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03737630 (first posted 09 November 2018). ">NCT03737630</a>; <a href="./references#CD006112-bbs2-0022" title="OzaydinZ , SavciS , SaglamM , ArikanH , Inal-InceD , Vardar-YagliN , et al. Effects of inspiratory muscle training on functional capacity and muscle strength in patients with mild cystic fibrosis. In: European Respiratory Society Annual Congress; 2010 Sep 18-22; Barcelona, Spain. 2010. [ABSTRACT NO.: 5134] [CFGD REGISTER: PE235] ">Ozaydin 2010</a>); three of these studies were identified from the study registry <a href="https://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and although now closed, have no results published to date (<a href="./references#CD006112-bbs2-0018" title="EmirzaC , AslanGK , KilincAA , CokugrasHC . Effect of expiratory muscle training on peak cough flow in children and adolescents with cystic fibrosis. erscongress.org/images/congress-2020/programme/detailedprogramme/ExportFinalProgram_31082020021051.pdf (accessed 15 October 2020):198. [ABSTRACT NO.: 2968] NCT03873688. Effects of expiratory muscle training on cough efficacy in children and adolescents with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03873688 (first posted 13 March 2019). ">Emirza 2020</a>; <a href="./references#CD006112-bbs2-0020" title="NCT03190031. Respiratory muscle training in CF patients (MUCOMUREE) [Respiratory muscle training in patients with cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03190031 (first posted 16 June 2017). ">NCT03190031</a>; <a href="./references#CD006112-bbs2-0021" title="NCT03737630. Inspiratory muscle training in individuals with cystic fibrosis [Effects of inspiratory muscle training in individuals who have cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03737630 (first posted 09 November 2018). ">NCT03737630</a>). </p> </section> <section id="CD006112-sec-0042"> <h4 class="title">Included studies</h4> <p>A full comparison of the included studies can be found in the table (<a href="./references#CD006112-sec-0116" title="">Characteristics of included studies</a>). </p> <section id="CD006112-sec-0043"> <h5 class="title">Study design</h5> <p>All studies were RCTs. Of these, eight were of a parallel design (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>) and two studies had a cross‐over design (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). One study utilised a three‐way comparison between two different RMT interventions and control condition (<a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>). The duration of the intervention ranged from four (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>) to 12 weeks (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>) and all outcomes were recorded at the end of the study period. All studies were relatively small with the number of participants ranging from 11 (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>) to 39 (<a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>). The studies were run in a number of different countries: USA (<a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>); UK (<a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>); Netherlands (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>); Switzerland (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>); Canada (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>); Russia (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>); Austria (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>); and Turkey (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). While most were single‐centre studies (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>), it was unclear if three studies were single or multicentre (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>). </p> </section> <section id="CD006112-sec-0044"> <h5 class="title">Participants</h5> <p>Participant characteristics were not consistently reported across studies. Two studies did not report the exact mean age or age range of participants, but indicated that they were adults (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>). One further study explicitly stated that participants were adults and gave a mean age of 22.5 years (<a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>). Three studies reported age ranges that included children, adolescents and young adults; 6 to 18 years (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>), 9 to 18 years (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>), and 9 to 24 years (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). The remaining four studies gave more detailed information on participant age, reporting mean ages and the standard deviation according to treatment groups (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). In each study, ages were similar between groups, but while the mean age in two studies suggested that participants were young adults (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>), the mean age in the remaining studies indicated children and adolescent participants (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). </p> <p>Six of the studies did not report on the gender split in participants (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>). Four studies reported on gender split by treatment group. One study had equal numbers of males and females (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>), one study had slightly more females than males (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>), and in the remaining studies there were slightly more males than females (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>). </p> </section> <section id="CD006112-sec-0045"> <h5 class="title">Interventions</h5> <p>There was great variation as to the method and level of training employed by the included studies. In the intervention group, three studies used 80% of maximal effort (<a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>); one study used 60% of maximal effort (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>); one study used 40% of maximal effort (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>); two studies used 30% of maximal effort (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>) and three studies did not specify the level of resistance (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). The frequency of training also varied. In two studies the frequency and duration of training was unclear (<a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>). Five studies used similar training regimens (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). Of these, two studies used a duration for each session of 10 to 15 minutes twice daily (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>); two studies used 15 minutes twice daily (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>) and one study used 30 minutes in total daily (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>). The remaining two studies used a regimen of training three times per week, but the duration of the sessions either varied (<a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>) or was not stated (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>). </p> </section> <section id="CD006112-sec-0046"> <h5 class="title">Outcomes</h5> <p>The outcome measures selected by the studies also varied greatly. All studies reported some measure of respiratory or inspiratory muscle strength. Most studies reported at least one measure of pulmonary function, principally FEV<sub>1</sub> (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>) and FVC (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). Seven studies reported on exercise capacity (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>), specifically maximal oxygen uptake (VO<sub>2max</sub>) (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>) and exercise duration (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>;<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a> ). One study reported on exercise capacity but did not specify the outcome measure (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>). </p> <p>Three studies reported a measure of health‐related quality of life using either the Chronic Respiratory Disease Questionnaire (CRDQ) (<a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>) or a combination of the Cystic Fibrosis Questionnaire (CFQ) and the Cystic Fibrosis Clinical Score (CFCS) (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). Other studies also reported on related outcomes such as perceived breathlessness (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>) and fatigue (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>). </p> </section> </section> <section id="CD006112-sec-0047"> <h4 class="title">Excluded studies</h4> <p>A total of seven studies were excluded (<i>see</i><a href="./references#CD006112-sec-0117" title="">Characteristics of excluded studies</a>). One study was excluded as the allocation was not randomised (<a href="./references#CD006112-bbs2-0013" title="KeensTG , KrastinsIRB , WannamakerE , LevisonH , CrozierDN , BryanAC . Ventilatory muscle endurance training in normal subjects and patients with cystic fibrosis. American Review of Respiratory Disease1977;116(5):853-60. ">Keens 1977</a>), whereas two studies were excluded as they were not interventional trials (<a href="./references#CD006112-bbs2-0014" title="PattersonJE , BradleyJM . Inspiratory muscle training in adult patients with cystic fibrosis: a randomised controlled trial to evaluate the efficacy of the test of incremental respiratory endurance (TIRE). Thorax2004;59(Suppl II):ii13. [ABSTRACT NO: S36] [CENTRAL: 518434] [CFGD REGISTER: PE236] ">Patterson 2004</a>; <a href="./references#CD006112-bbs2-0016" title="SartoriR , BarbiE , PoliF , RonfaniL , MarchettiF , AmaddeO , et al. Respiratory training with a specific device in cystic fibrosis: a prospective study. Journal of Cystic Fibrosis2008;7(4):313-9. ">Sartori 2008</a>). A further three studies were excluded as the intervention was not appropriate and could not be deemed a form of RMT (<a href="./references#CD006112-bbs2-0011" title="HowardJ , BradleyJ , HewittO , ElbornS . The active cycle of breathing (ACBT) is a more effective method of airway clearance in cystic fibrosis (CF) patients than the test of incremental respiratory endurance (TIRE). Pediatric Pulomonology2000;30 Suppl 20:304. [ABSTRACT NO.: 457] [CFGD REGISTER: PE116] ">Howard 2000</a>; <a href="./references#CD006112-bbs2-0012" title="IronsJY , KennyD , ChangAB . Let's sing out!: The effect of singing on quality of life and lung function of children and adolescents with cystic fibrosis. Www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ID=839442009. [CFGD REGISTER: PE185a ] 5500100000010548 IronsJY , KennyDT , McElreaM , ChangAB . Singing therapy for young people with cystic fibrosis: a randomized controlled pilot study. Music and Medicine2012;4(3):136-45. [CFGD REGISTER: PE185b ] 5500100000007892 ">Irons 2012</a>; <a href="./references#CD006112-bbs2-0017" title="VivodtzevI , DecorteN , WuyamB , GonnetN , DurieuI , LevyP , et al. Benefits of neuromuscular electrical stimulation prior to endurance training in patients with cystic fibrosis and severe pulmonary dysfunction. Chest2013;143(2):485-93. ">Vivodtzev 2013</a>). Although one study used a form of RMT, it was combined with another form of exercise training, and was excluded as changes could not be attributed to RMT alone (<a href="./references#CD006112-bbs2-0015" title="Santana-SosaE , Gonzalez-SaizL , GroeneveldIF , Villa-AsensiJR , Barrio Gomez de AgueroMI , FleckSJ , et al. Benefits of combining inspiratory muscle with 'whole muscle' training in children with cystic fibrosis: a randomised controlled trial. British Journal of Sports Medicine2014;48(20):1513-7. [CENTRAL: CN-00874806] [CFGD REGISTER: PE201] [PMID: 23681502]">Santana‐Sosa 2014</a>). </p> <section id="CD006112-sec-0048"> <h5 class="title">Studies awaiting classification</h5> <p>There are five studies currently listed as 'awaiting classification', which require more detail about the study prior to classification (Emirza 2020; <a href="./references#CD006112-bbs2-0019" title="GiacomodonatoB , GrazianoL , CurziM , PerelliT , De SanctisS , VarchettaM , et al. Respiratory muscle endurance training with normocapnic hyperpnea in patients with cystic fibrosis. A randomized controlled study. Journal of Cystic Fibrosis2015;14 Suppl 1:S41. [ABSTRACT NO.: WS21.10] [CFGD REGISTER: PE217] ">Giacomodonato 2015</a>; <a href="./references#CD006112-bbs2-0020" title="NCT03190031. Respiratory muscle training in CF patients (MUCOMUREE) [Respiratory muscle training in patients with cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03190031 (first posted 16 June 2017). ">NCT03190031</a>; <a href="./references#CD006112-bbs2-0021" title="NCT03737630. Inspiratory muscle training in individuals with cystic fibrosis [Effects of inspiratory muscle training in individuals who have cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03737630 (first posted 09 November 2018). ">NCT03737630</a>; <a href="./references#CD006112-bbs2-0022" title="OzaydinZ , SavciS , SaglamM , ArikanH , Inal-InceD , Vardar-YagliN , et al. Effects of inspiratory muscle training on functional capacity and muscle strength in patients with mild cystic fibrosis. In: European Respiratory Society Annual Congress; 2010 Sep 18-22; Barcelona, Spain. 2010. [ABSTRACT NO.: 5134] [CFGD REGISTER: PE235] ">Ozaydin 2010</a>). Three of these studies are currently published as abstracts only (Emirza 2020; <a href="./references#CD006112-bbs2-0019" title="GiacomodonatoB , GrazianoL , CurziM , PerelliT , De SanctisS , VarchettaM , et al. Respiratory muscle endurance training with normocapnic hyperpnea in patients with cystic fibrosis. A randomized controlled study. Journal of Cystic Fibrosis2015;14 Suppl 1:S41. [ABSTRACT NO.: WS21.10] [CFGD REGISTER: PE217] ">Giacomodonato 2015</a>; <a href="./references#CD006112-bbs2-0022" title="OzaydinZ , SavciS , SaglamM , ArikanH , Inal-InceD , Vardar-YagliN , et al. Effects of inspiratory muscle training on functional capacity and muscle strength in patients with mild cystic fibrosis. In: European Respiratory Society Annual Congress; 2010 Sep 18-22; Barcelona, Spain. 2010. [ABSTRACT NO.: 5134] [CFGD REGISTER: PE235] ">Ozaydin 2010</a>). Two of these studies were identified from clinicaltrials.gov and have no results published to date (<a href="./references#CD006112-bbs2-0020" title="NCT03190031. Respiratory muscle training in CF patients (MUCOMUREE) [Respiratory muscle training in patients with cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03190031 (first posted 16 June 2017). ">NCT03190031</a>; <a href="./references#CD006112-bbs2-0021" title="NCT03737630. Inspiratory muscle training in individuals with cystic fibrosis [Effects of inspiratory muscle training in individuals who have cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03737630 (first posted 09 November 2018). ">NCT03737630</a>). </p> <section id="CD006112-sec-0049"> <h6 class="title">Study design</h6> <p>Five studies stated that participants were randomised to either the control or intervention group, but gave no further details regarding study design (<a href="./references#CD006112-bbs2-0018" title="EmirzaC , AslanGK , KilincAA , CokugrasHC . Effect of expiratory muscle training on peak cough flow in children and adolescents with cystic fibrosis. erscongress.org/images/congress-2020/programme/detailedprogramme/ExportFinalProgram_31082020021051.pdf (accessed 15 October 2020):198. [ABSTRACT NO.: 2968] NCT03873688. Effects of expiratory muscle training on cough efficacy in children and adolescents with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03873688 (first posted 13 March 2019). ">Emirza 2020</a>; <a href="./references#CD006112-bbs2-0019" title="GiacomodonatoB , GrazianoL , CurziM , PerelliT , De SanctisS , VarchettaM , et al. Respiratory muscle endurance training with normocapnic hyperpnea in patients with cystic fibrosis. A randomized controlled study. Journal of Cystic Fibrosis2015;14 Suppl 1:S41. [ABSTRACT NO.: WS21.10] [CFGD REGISTER: PE217] ">Giacomodonato 2015</a>; <a href="./references#CD006112-bbs2-0020" title="NCT03190031. Respiratory muscle training in CF patients (MUCOMUREE) [Respiratory muscle training in patients with cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03190031 (first posted 16 June 2017). ">NCT03190031</a>; <a href="./references#CD006112-bbs2-0021" title="NCT03737630. Inspiratory muscle training in individuals with cystic fibrosis [Effects of inspiratory muscle training in individuals who have cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03737630 (first posted 09 November 2018). ">NCT03737630</a>; <a href="./references#CD006112-bbs2-0022" title="OzaydinZ , SavciS , SaglamM , ArikanH , Inal-InceD , Vardar-YagliN , et al. Effects of inspiratory muscle training on functional capacity and muscle strength in patients with mild cystic fibrosis. In: European Respiratory Society Annual Congress; 2010 Sep 18-22; Barcelona, Spain. 2010. [ABSTRACT NO.: 5134] [CFGD REGISTER: PE235] ">Ozaydin 2010</a>). </p> </section> <section id="CD006112-sec-0050"> <h6 class="title">Participants</h6> <p>One study included 10 participants with CF aged between 21 and 40 years; there were six males and four females (<a href="./references#CD006112-bbs2-0019" title="GiacomodonatoB , GrazianoL , CurziM , PerelliT , De SanctisS , VarchettaM , et al. Respiratory muscle endurance training with normocapnic hyperpnea in patients with cystic fibrosis. A randomized controlled study. Journal of Cystic Fibrosis2015;14 Suppl 1:S41. [ABSTRACT NO.: WS21.10] [CFGD REGISTER: PE217] ">Giacomodonato 2015</a>). Another study included 28 participants with CF with a mean (SD) age 13.18 (3.65) years and a mean (SD) baseline value for FEV<sub>1</sub> % predicted of 89.51% (19.47) (<a href="./references#CD006112-bbs2-0022" title="OzaydinZ , SavciS , SaglamM , ArikanH , Inal-InceD , Vardar-YagliN , et al. Effects of inspiratory muscle training on functional capacity and muscle strength in patients with mild cystic fibrosis. In: European Respiratory Society Annual Congress; 2010 Sep 18-22; Barcelona, Spain. 2010. [ABSTRACT NO.: 5134] [CFGD REGISTER: PE235] ">Ozaydin 2010</a>). A third study included 28 participants with CF aged 8 to 18 years but gave no further details (<a href="./references#CD006112-bbs2-0018" title="EmirzaC , AslanGK , KilincAA , CokugrasHC . Effect of expiratory muscle training on peak cough flow in children and adolescents with cystic fibrosis. erscongress.org/images/congress-2020/programme/detailedprogramme/ExportFinalProgram_31082020021051.pdf (accessed 15 October 2020):198. [ABSTRACT NO.: 2968] NCT03873688. Effects of expiratory muscle training on cough efficacy in children and adolescents with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03873688 (first posted 13 March 2019). ">Emirza 2020</a>). Two studies included 10 people with CF (<a href="./references#CD006112-bbs2-0021" title="NCT03737630. Inspiratory muscle training in individuals with cystic fibrosis [Effects of inspiratory muscle training in individuals who have cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03737630 (first posted 09 November 2018). ">NCT03737630</a>) and 38 people with CF (<a href="./references#CD006112-bbs2-0020" title="NCT03190031. Respiratory muscle training in CF patients (MUCOMUREE) [Respiratory muscle training in patients with cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03190031 (first posted 16 June 2017). ">NCT03190031</a>), but gave no further details of participants.  </p> </section> <section id="CD006112-sec-0051"> <h6 class="title">Interventions</h6> <p>The Giacomodonato study allocated participants to either RME training with normocapnic hyperpnoea or standard chest physiotherapy (<a href="./references#CD006112-bbs2-0019" title="GiacomodonatoB , GrazianoL , CurziM , PerelliT , De SanctisS , VarchettaM , et al. Respiratory muscle endurance training with normocapnic hyperpnea in patients with cystic fibrosis. A randomized controlled study. Journal of Cystic Fibrosis2015;14 Suppl 1:S41. [ABSTRACT NO.: WS21.10] [CFGD REGISTER: PE217] ">Giacomodonato 2015</a>). Participants in the intervention group were asked to maintain 70% of 12s MVV until this could not be sustained, for 15 minutes daily over eight weeks. </p> <p>Ozaydin allocated 14 participants to inspiratory muscle training (IMT) using a threshold loading device at 30% to 80% maximal inspiratory pressure (MIP) and 14 participants to sham training at 10% MIP, for 20 minutes on five days per week (<a href="./references#CD006112-bbs2-0022" title="OzaydinZ , SavciS , SaglamM , ArikanH , Inal-InceD , Vardar-YagliN , et al. Effects of inspiratory muscle training on functional capacity and muscle strength in patients with mild cystic fibrosis. In: European Respiratory Society Annual Congress; 2010 Sep 18-22; Barcelona, Spain. 2010. [ABSTRACT NO.: 5134] [CFGD REGISTER: PE235] ">Ozaydin 2010</a>). </p> <p>The Emirza study allocated participants to either expiratory muscle training at 30% of maximal expiratory pressure (MEP) or sham training using the same device set at the lowest pressure setting of 5 cm H2O (<a href="./references#CD006112-bbs2-0018" title="EmirzaC , AslanGK , KilincAA , CokugrasHC . Effect of expiratory muscle training on peak cough flow in children and adolescents with cystic fibrosis. erscongress.org/images/congress-2020/programme/detailedprogramme/ExportFinalProgram_31082020021051.pdf (accessed 15 October 2020):198. [ABSTRACT NO.: 2968] NCT03873688. Effects of expiratory muscle training on cough efficacy in children and adolescents with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03873688 (first posted 13 March 2019). ">Emirza 2020</a>). Training was completed for at least five days a week during a six‐week period.  </p> <p>In NCT03190031 participants performed endurance respiratory muscle training at 70% to 80% of MVV or IMT at 70% to 80% of MIP for 20 minutes, five times a week for eight weeks (<a href="./references#CD006112-bbs2-0020" title="NCT03190031. Respiratory muscle training in CF patients (MUCOMUREE) [Respiratory muscle training in patients with cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03190031 (first posted 16 June 2017). ">NCT03190031</a>). No further details were available on either study </p> <p>Investigators in NCT03737630 compared moderate‐load IMT to low‐load IMT, but again no further details were available (<a href="./references#CD006112-bbs2-0021" title="NCT03737630. Inspiratory muscle training in individuals with cystic fibrosis [Effects of inspiratory muscle training in individuals who have cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03737630 (first posted 09 November 2018). ">NCT03737630</a>). .  </p> </section> <section id="CD006112-sec-0052"> <h6 class="title">Outcomes</h6> <p>The Giacomodonato study stated that it had measured RME, six‐minute walk test (6MWT) distance, health‐related quality of life (HRQoL) using the CFQ and lung function (FVC, FEV<sub>1</sub>, MIP, MEP) pre‐ and post‐intervention. However, the abstract only reported 6MWT distance between the groups following the intervention and we await the full publication for further results (<a href="./references#CD006112-bbs2-0019" title="GiacomodonatoB , GrazianoL , CurziM , PerelliT , De SanctisS , VarchettaM , et al. Respiratory muscle endurance training with normocapnic hyperpnea in patients with cystic fibrosis. A randomized controlled study. Journal of Cystic Fibrosis2015;14 Suppl 1:S41. [ABSTRACT NO.: WS21.10] [CFGD REGISTER: PE217] ">Giacomodonato 2015</a>). </p> <p>The Ozaydin study also measured the 6MWT distance and pulmonary function; in addition the investigators measured peripheral muscle strength (hand grip, shoulder abductors, elbow flexors) (<a href="./references#CD006112-bbs2-0022" title="OzaydinZ , SavciS , SaglamM , ArikanH , Inal-InceD , Vardar-YagliN , et al. Effects of inspiratory muscle training on functional capacity and muscle strength in patients with mild cystic fibrosis. In: European Respiratory Society Annual Congress; 2010 Sep 18-22; Barcelona, Spain. 2010. [ABSTRACT NO.: 5134] [CFGD REGISTER: PE235] ">Ozaydin 2010</a>). </p> <p>The Emirza study measured peak cough flow, MIP, MEP, spirometry and 6MWT. They reported significant improvements in peak cough flow and MEP, and non‐significant differences for other measures (although values were not reported). We await the full publication for further details of the results (<a href="./references#CD006112-bbs2-0018" title="EmirzaC , AslanGK , KilincAA , CokugrasHC . Effect of expiratory muscle training on peak cough flow in children and adolescents with cystic fibrosis. erscongress.org/images/congress-2020/programme/detailedprogramme/ExportFinalProgram_31082020021051.pdf (accessed 15 October 2020):198. [ABSTRACT NO.: 2968] NCT03873688. Effects of expiratory muscle training on cough efficacy in children and adolescents with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03873688 (first posted 13 March 2019). ">Emirza 2020</a>).  </p> <p>Of the two studies listed on the registry, one measured change from baseline in posture, QoL, respiratory muscle strength, pulmonary function and functional capacity (<a href="./references#CD006112-bbs2-0021" title="NCT03737630. Inspiratory muscle training in individuals with cystic fibrosis [Effects of inspiratory muscle training in individuals who have cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03737630 (first posted 09 November 2018). ">NCT03737630</a>). The second study assessed RME measured by an incremental hyperpnea test, respiratory muscle strength, cycling perfomance and HRQoL (<a href="./references#CD006112-bbs2-0020" title="NCT03190031. Respiratory muscle training in CF patients (MUCOMUREE) [Respiratory muscle training in patients with cystic fibrosis]. clinicaltrials.gov/ct2/show/NCT03190031 (first posted 16 June 2017). ">NCT03190031</a>).  </p> </section> </section> </section> </section> <section id="CD006112-sec-0053"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias judgements were made for each of the following domains using the Cochrane risk of bias tool. </p> <section id="CD006112-sec-0054"> <h4 class="title">Allocation</h4> <section id="CD006112-sec-0055"> <h5 class="title">Generation of allocation sequence</h5> <p>Although all 10 of the included studies state that they had randomised their participants to the treatment groups, only two studies indicated the method of allocation by stating that they employed the minimisation method (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>) or pre‐filled envelopes specifying group assignments generated by a computer‐based programme (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). We graded these two studies as having a low risk of bias, whereas we graded the remaining eight studies as having an unclear risk of bias. </p> </section> <section id="CD006112-sec-0056"> <h5 class="title">Concealment of allocation sequence</h5> <p>Of the included studies, only one study was deemed to have a low risk of bias in regards to concealment of allocation (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). The use of pre‐filled envelopes specifying group allocation enabled blinding of both participants and physiotherapists prior to the commencement of training programmes. All other studies made no specific references as to how, or even whether, investigators concealed allocation. Therefore, these remaining studies were deemed to have an unclear risk of bias in relation to this criteria.  </p> </section> </section> <section id="CD006112-sec-0057"> <h4 class="title">Blinding</h4> <section id="CD006112-sec-0058"> <h5 class="title">Performance bias</h5> <p>We graded all the included studies as having a high risk of performance bias since in all studies there was a clear difference between the experimental and control training. This ranged from no details being provided for the control group (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>) and 'no training' (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>), through to minimal training and "sham" training (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>) and standard chest physiotherapy (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). Although the methodological difficulties of blinding the participants to this type of intervention are acknowledged, this can be addressed in some cases (e.g. RMT versus sham) but not all (e.g. training versus no training). </p> </section> <section id="CD006112-sec-0059"> <h5 class="title">Detection bias</h5> <p>One study blinded the outcome assessors for all assessments, although the paper did not state if the same assessor was used (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). Two studies blinded the outcome assessors at the final data collection session, but did not state whether this was the case at the initial assessment or if the same assessors were used (<a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>). A third study reports that the observers were blinded, although it does not expand on the level of this (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). The remaining six studies make no overt reference to any blinding of outcome assessors and are deemed a high risk of bias (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>). </p> </section> </section> <section id="CD006112-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>Only one study referred to the intention‐to‐treat principle (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). The trial reported that six out of 22 participants withdrew from the study, of these four participants discontinued the study in the control period, suggesting that withdrawal was not directly linked to the intervention in these cases. However, participants who withdrew did have a tendency to be older with characteristics of more advanced lung disease (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). We judged this study to have a low risk of bias. We judged a further study to have a low risk of bias as investigators stated that there were no withdrawals, although some participants did not complete all training sessions and it was unclear whether investigators used the intention‐to‐treat principle (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>).  </p> <p>Three studies were judged to have a high risk of bias (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>). In the Asher study, two participants did not perform one of the post‐treatment outcome measures, due to expiration up to residual volume resulting in coughing and there are no details on the regimen of the control group (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). In the de Jong study, one participant in the intervention group withdrew after experiencing earache at a training intensity equating to 40% PI<sub>max</sub> (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>). In the Sawyer study, two participants did not complete their pulmonary function tests: one was due to an oversight on the part of the researchers; and the other did not complete the test. There is no indication as to which group these participants are from (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>). </p> <p>The remaining five studies were judged to have an unclear risk of bias (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>). Two studies gave limited information on withdrawals; in the Amelina study, one participant in the intervention group did not complete the trial (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>) and in the Chatham study, three participants in the control group did not complete the trial (<a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>). Neither of these two studies offered any explanation for these withdrawals; however, as they are both abstracts published in conference proceedings and that there are likely to be editorial constraints responsible for this. Furthermore, both trials failed to provide statistical data on their control groups, merely stating that there was no change in their outcomes; therefore they have been graded as having an unclear risk of bias. The remaining three trials do not provide any information with regards to participant withdrawals (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>). </p> </section> <section id="CD006112-sec-0061"> <h4 class="title">Selective reporting</h4> <p>One study reported on all outcome measures selected, although some health‐related quality of life domains were unreported; nevertheless the study was deemed to have a low risk of selective reporting bias (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). One study reported that the investigators carried out post‐training measures of pulmonary function but do not report the results (<a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>). It is acknowledged that this study is only published as an abstract; however, there is a potential risk of bias due to the limited reporting of their outcomes. Likewise for the study by Amelina, two outcomes (respiratory muscle strength and dyspnoea) are reported to have been analysed, but no data are provided for them (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>). There was insufficient information provided by the other publications to make a judgement on the risk of bias due to selective reporting from seven trials and have been judged to have an unclear risk of bias (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a> ).  </p> </section> <section id="CD006112-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>All the included studies have been graded an unclear risk of bias as none provided sufficient information to arrive at a definitive conclusion. </p> </section> </section> <section id="CD006112-sec-0063"> <h3 class="title" id="CD006112-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD006112-tbl-0001"><b>Summary of findings 1</b> Summary of findings: respiratory muscle training compared with control for cystic fibrosis</a> </p> <p>Due to the lack of studies using comparable intensities of RMT or outcome measures, or both, we are unable to conduct meta‐analyses at this time; but all available data are presented in the <a href="./references#CD006112-sec-0092" title="">Data and analyses</a> section. All outcome measures were recorded at the end of the study period in each study. </p> <p>In the summary of findings table, the quality of the evidence has been graded for pre‐defined outcomes (see above) and definitions of these gradings provided. The quality of evidence for the key parameters was graded as very low (<a href="./full#CD006112-tbl-0001">summary of findings Table 1</a>). </p> <section id="CD006112-sec-0064"> <h4 class="title">Primary outcomes</h4> <section id="CD006112-sec-0065"> <h5 class="title">1. Pulmonary function</h5> <p>Eight of the 10 included studies reported some measure of pulmonary function; two included studies did not report on this outcome (<a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0008" title="CampbellA , EnrightS , UnnithamV . The effect of inspiratory muscle training on the measurement of resting energy expenditure in adult patients with cystic fibrosis and in health subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146b] HewardC , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on lung volumes and diaphragm structure in cystic fibrosis patients and in healthy subjects. European Respiratory Journal2000;16(Suppl 31):153S. [CFGD REGISTER: PE146a] WithnallL , EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithamV . The effect of inspiratory muscle training on exercise capacity and inspiratory muscle function in cystic fibrosis patients and in healthy subjects. European Repiratory Journal2000;16(Suppl31):330S. [CFGD REGISTER: PE146c] ">Heward 2000</a>). The quality of the evidence was assessed for FEV<sub>1</sub> % predicted and FVC % predicted and judged to be very low (<a href="./full#CD006112-tbl-0001">summary of findings Table 1</a>). </p> <section id="CD006112-sec-0066"> <h6 class="title">a. FEV<sub>1</sub> </h6> <p>Eight studies reported FEV<sub>1</sub> in either litres (L) (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>), % predicted (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>) or using the z score (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>); one study did not define the unit of measurement in the two published abstracts (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>). We judged the quality of the evidence to be very low (<a href="./full#CD006112-tbl-0001">summary of findings Table 1</a>). </p> <p>One study reported FEV<sub>1</sub> (L) at six weeks (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>) and two studies reported at eight weeks (<a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>). There was no difference (P &gt; 0.05) between groups in terms of FEV<sub>1</sub> measured in L in any study irrespective of working at 80% (<a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>), 60% (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>), 40% (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>) or 20% (<a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>) of maximal effort (<a href="./references#CD006112-fig-0001" title="">Analysis 1.1</a>; <a href="./references#CD006112-fig-0005" title="">Analysis 2.1</a>; <a href="./references#CD006112-fig-0007" title="">Analysis 3.1</a>; <a href="./references#CD006112-fig-0033" title="">Analysis 5.1</a>). </p> <p>One study reported data for analysis for FEV<sub>1</sub> % predicted at 40% of maximal capacity at six weeks (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>) and one study reported post treatment data and change from baseline data for FEV<sub>1</sub> % predicted at 30% of maximal capacity at eight weeks (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). Again no differences were found between treatment groups for any comparison (<a href="./references#CD006112-fig-0008" title="">Analysis 3.2</a>; <a href="./references#CD006112-fig-0012" title="">Analysis 4.1</a>; <a href="./references#CD006112-fig-0013" title="">Analysis 4.2</a>). A further study comparing 30% of maximal capacity to control reported on FEV<sub>1</sub> % predicted, but only presented within‐group changes (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>). One study did not specify the level of resistance, but stated there was no difference in FEV<sub>1</sub> % predicted after eight weeks of training (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). </p> <p>One cross‐over study (unspecified level of resistance) reported the FEV<sub>1</sub> z score and found no difference between the treatment groups (P = 0.436) (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). </p> <p>One study did not specify the level of resistance or units of measurement and did not report any data, but stated that there was no change in FEV<sub>1</sub> in either the RMT or the control group at 12 weeks (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>). </p> <p><b>b. FVC</b> </p> <p>Seven studies reported FVC in either L (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>), % predicted (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>) or using the z score (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>); one study did not define the unit of measurement in the two published abstracts (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>). We judged the quality of the evidence to be very low (<a href="./full#CD006112-tbl-0001">summary of findings Table 1</a>). </p> <p>Between‐group comparisons did not reveal a difference in FVC (L) irrespective of working at 80% at eight weeks (<a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>), 40% at six weeks (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>) or 20% at eight weeks (<a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>) of maximal effort (P &gt; 0.05) (<a href="./references#CD006112-fig-0002" title="">Analysis 1.2</a>; <a href="./references#CD006112-fig-0008" title="">Analysis 3.2</a>; <a href="./references#CD006112-fig-0034" title="">Analysis 5.2</a>). </p> <p>This was also true for FVC % predicted as reported by two studies: one study reported data for analysis for FVC % predicted at 40% of maximal capacity at six weeks (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>) and the second at 30% of maximal capacity at eight weeks (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). Again, no differences were found between treatment groups (<a href="./references#CD006112-fig-0010" title="">Analysis 3.4</a>; <a href="./references#CD006112-fig-0014" title="">Analysis 4.3</a> ). Zeren also found no difference between treatments in the change from baseline in FVC % predicted at the same time point (<a href="./references#CD006112-fig-0015" title="">Analysis 4.4</a>). A further study comparing 30% of maximal capacity to control only reported within‐group improvement in FVC % predicted (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>). </p> <p>There was no difference in FVC z score between groups as reported by Bieli (P = 0.472) (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). </p> <p>One study did not specify the level of resistance or units of measurement and did not report any data, but stated that there was no change in FVCin either the RMT or the control group at 12 weeks (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>). </p> <p><b>c. PEF</b> </p> <p>One study reported absolute post‐treatment values and change from baseline scores in PEF % predicted at eight weeks (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>); there were no differences found between groups (<a href="./references#CD006112-fig-0016" title="">Analysis 4.5</a>; <a href="./references#CD006112-fig-0017" title="">Analysis 4.6</a>).  </p> </section> </section> <section id="CD006112-sec-0067"> <h5 class="title">2. Exercise capacity</h5> <p>Seven studies reported some measure of exercise capacity (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). Details are given below for most studies, however, one study did not provide any units of measurement nor was there any explanation as to the method of assessment; but investigators did state that there was no improvement observed (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>). The quality of the evidence was judged to be very low (<a href="./full#CD006112-tbl-0001">summary of findings Table 1</a>). </p> <section id="CD006112-sec-0068"> <h6 class="title">a. VO<sub>2max</sub> </h6> <p>Three studies reported VO<sub>2max</sub> as mL/kg/min<sup>‐1</sup>, but not in a form that we could analyse (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>). One study reported no difference at six weeks between groups when working at 40% of maximal effort (P = 0.99) (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>). A further study reported no difference in the mean (SD) VO2<sub>max</sub> (mL/kg/min<sup>‐1</sup>) at 31.6 (5.0) mL/kg/min<sup>‐1</sup> and 29.9 (6.4) mL/kg/min<sup>‐1</sup> pre and post‐intervention at eight weeks (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). A third study only reported within‐group improvements, with no data to allow inclusion in our analysis (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>). </p> </section> <section id="CD006112-sec-0069"> <h6 class="title">b. Exercise duration</h6> <p>Two studies reported this outcome (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>). The cross‐over study (unspecified level of resistance) did not provide data we could analyse, but reported no difference between groups in exercise duration measured using a constant workload cycling test, (P = 0.169) (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). In the second study, between‐group comparisons found a 10% improvement when working at 60% of maximal effort (P &lt; 0.03) (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>). </p> </section> <section id="CD006112-sec-0070"> <h6 class="title">C. Six‐minute walk test</h6> <p>One study reported this outcome at eight weeks (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). While the distance achieved improved from baseline in both groups during the study, there was no difference in between‐group comparisons of absolute distance walked or the change from baseline (<a href="./references#CD006112-fig-0018" title="">Analysis 4.7</a>; <a href="./references#CD006112-fig-0019" title="">Analysis 4.8</a>). </p> </section> </section> <section id="CD006112-sec-0071"> <h5 class="title">3. Health‐related quality of life</h5> <p>Three studies reported a measure of health‐related quality of life; two studies used the CRDQ (<a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>) and one study used the CFQ and the CFCS (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). The quality of the evidence was judged to be very low (<a href="./full#CD006112-tbl-0001">summary of findings Table 1</a>). </p> <p>The CRDQ evaluates four domains considered important to individuals with chronic airflow obstruction; dyspnoea, mastery, fatigue and emotion (<a href="./references#CD006112-bbs2-0030" title="ChauvinA , RupleyL , MeyersK , JohnsonK , EasonJ . Outcomes in Cardiopulmonary Physical Therapy: Chronic Respiratory Disease Questionnaire (CRQ). Cardiopulmonary Physical Therapy Journal2008;19(2):61-7.">Chauvin 2008</a>). Enright found no difference between groups in the two parameters of mastery and emotion when working at 80% of maximal effort (<a href="./references#CD006112-fig-0003" title="">Analysis 1.3</a>; <a href="./references#CD006112-fig-0004" title="">Analysis 1.4</a>); however, Chatham did find an improvement between groups in these parameters at the same level of effort (P &lt; 0.01) (<a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>). Using the CFQ, Bieli found no difference in health‐related quality of life between treatment groups (no specified level of resistance) (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). </p> <p>Bieli also measured symptom severity using the CF clinical score (CFCS) which indicates overall symptom severity, but no difference was reported between groups at baseline or post‐intervention (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). </p> </section> <section id="CD006112-sec-0072"> <h5 class="title">Secondary outcomes</h5> <section id="CD006112-sec-0073"> <h6 class="title">1. Respiratory muscle function</h6> <p>Four studies reported PI<sub>max</sub> (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>), but only two studies provided data for analysis (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). The quality of the evidence was judged to be very low (<a href="./full#CD006112-tbl-0001">summary of findings Table 1</a>). </p> <p><b>a. PI<sub>max</sub> </b> </p> <p>After data analysis, Sawyer reported a greater increase in favour of the treatment group (60% of maximal effort) at 10 weeks, MD 26.00 (95% CI 8.63 to 43.47) (<a href="./references#CD006112-fig-0006" title="">Analysis 2.2</a>). The second study compared 30% resistance to control at eight weeks (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>); data again showed greater absolute values, MD 14.63 (95% CI 5.63 to 23.63) and a greater increase from baseline in favour of the treatment group, MD 24.26 (95% CI 19.31 to 30.07) (<a href="./references#CD006112-fig-0020" title="">Analysis 4.9</a>; <a href="./references#CD006112-fig-0021" title="">Analysis 4.10</a>). A third study compared 30% resistance to control, but only reported within‐group changes in PI<sub>max</sub> (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>). </p> <p>Asher (unspecified level of resistance) utilised two inspiratory measures (prevailing intramural pressure‐functional residual capacity (Pim‐FRC) and PI<sub>max</sub>) suggesting that one measurement technique was used but at two different lung volumes (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). The study reported changes in both measures in the RMT group (P &lt; 0.025 and P &lt; 0.05 respectively). The investigators also reported that, for the Pim‐FRC measure, only three participants registered an increase that was more than two SDs from the control group; and for the PI<sub>max</sub> measure, two participants had an increase greater than two SDs from the control values. </p> <p><b>b. IC</b> </p> <p>No studies reported this outcome.</p> <p><b>c. PE<sub>max</sub> </b> </p> <p>One study reported this outcome (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>); there was no difference in absolute or change values at eight weeks (<a href="./references#CD006112-fig-0022" title="">Analysis 4.11</a>; <a href="./references#CD006112-fig-0023" title="">Analysis 4.12</a>). </p> </section> <section id="CD006112-sec-0074"> <h6 class="title">2. Respiratory muscle strength and RME</h6> <p>Five studies reported RME (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>), but only three studies reported between‐group comparisons (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>). </p> <p>One study presented values for mean (SD) and a P value which we were able to include in our analysis (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>); results showed a difference in favour of the RMT group after six weeks, MD 12.00 (95% CI 0.55 to 23.45) (<a href="./references#CD006112-fig-0011" title="">Analysis 3.5</a>). The remaining two studies which did not specify the level of resistance, did not provide data we could analyse. Albinni reported an improvement in RME in the training group (P = 0.002) (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>). Bieli also reported that RME was longer in the training group (P &lt; 0.01) (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>). </p> <p>One study reported a within‐group improvement in the training group when working at 80% of maximal effort, but no data from the control group were reported (<a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>). Likewise the final study reported a within‐group improvement in the training group when working at 30% of maximal effort, but no data from the control group were reported (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>). </p> </section> <section id="CD006112-sec-0075"> <h6 class="title">3. Frequency and duration of respiratory infections, hospitalisations</h6> <p>No studies reported this outcome.</p> </section> <section id="CD006112-sec-0076"> <h6 class="title">4. Adherence to the IMT regimen</h6> <p>Zeren reported on adherence to the training programme based upon once weekly attendance at a supervised session and self‐reported diaries (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>); adherence was high after eight weeks, but there was no difference between groups (<a href="./references#CD006112-fig-0024" title="">Analysis 4.13</a>). </p> </section> <section id="CD006112-sec-0077"> <h6 class="title">5. Death or survival</h6> <p>No studies reported this outcome.</p> </section> <section id="CD006112-sec-0078"> <h6 class="title">6. Adverse effects</h6> <p>One study reported that one participant out of 16 experienced earache whilst performing IMT at 40% of maximal effort (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>). </p> </section> <section id="CD006112-sec-0079"> <h6 class="title">7. Costs</h6> <p>No studies reported this outcome.</p> </section> <section id="CD006112-sec-0080"> <h6 class="title">8. Oxygen saturation</h6> <p>One study reported resting oxygen saturations and change in oxygen saturations during test (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). Investigators found no differences between the groups observed in absolute post‐treatment values or in the change from baseline after eight weeks (<a href="./references#CD006112-fig-0025" title="">Analysis 4.14</a>; <a href="./references#CD006112-fig-0026" title="">Analysis 4.15</a>; <a href="./references#CD006112-fig-0027" title="">Analysis 4.16</a>; <a href="./references#CD006112-fig-0028" title="">Analysis 4.17</a>).  </p> </section> <section id="CD006112-sec-0081"> <h6 class="title">9.  Postural stability</h6> <p>One study reported measurements of postural stability at eight weeks using the 'Postural Stability Test' for static postural stability and the 'Limits of Stability Test' for dynamic postural stability (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). No differences were reported between groups in the overall score or individual section scores for either absolute post‐treatment values or in the change from baseline for these assessments (<a href="./references#CD006112-fig-0029" title="">Analysis 4.18</a>; <a href="./references#CD006112-fig-0030" title="">Analysis 4.19</a>; <a href="./references#CD006112-fig-0031" title="">Analysis 4.20</a>; <a href="./references#CD006112-fig-0032" title="">Analysis 4.21</a>). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006112-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006112-sec-0082"></div> <section id="CD006112-sec-0083"> <h3 class="title" id="CD006112-sec-0083">Summary of main results</h3> <p>The main finding of this Cochrane Review is that there is insufficient evidence to conclude if RMT has a positive effect on health outcomes in people with CF. This finding is based upon the small number of included studies (n = 10) and the small sample sizes used across the studies (n = 11 to 39). Of the 10 included studies, only six (comprising 134 participants) were fully published studies, highlighting the need for further research (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). Abstracts from conference proceedings limit the amount of detailed data that are presented and thus the data that can be extracted. </p> <p>Pulmonary function is routinely measured in clinical practice to monitor chest disease severity, specifically FEV<sub>1</sub> and FVC. No differences were reported between groups in pulmonary function, including both FEV<sub>1</sub> and FVC (measures either as L or % predicted) at any time point and in any study. Only three of the studies included in the review reported that they assessed health‐related quality of life (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>). Although no statistically significant difference was reported in two of the studies (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>), one study reported a significantly greater improvement in the two parameters of mastery and emotion in the treatment group (P &lt; 0.01) (<a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>). Six of the 10 studies reported some measure of exercise capacity (<a href="./references#CD006112-bbs2-0001" title="AlbinniS , RathR , RennerS , EichlerI . Additional inspiratory muscle training intensifies the beneficial effects of cycle ergonometer training in patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3 Suppl1:S63. [CFGD REGISTER: PE148a] EichlerI , RennerS , AlbinniS , NachbaurE , RathR . Inspiratory muscle training adds beneficial effects to cycle ergometer training in patients with cystic fibrosis. Pediatric Pulmonology2005;40 Suppl 28:320. [CFGD REGISTER: PE148b] ">Albinni 2004</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>; <a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). Of these, only one study reported a significant improvement with a 10% increase in exercise duration (P &lt; 0.03) when working at 60% of maximal effort (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>). </p> <p>Descriptive analysis of considered studies suggests that PI<sub>max</sub> and RME time are the measures that can best detect the effects of a RMT intervention. Although it is acknowledged that this is not supported by a meta‐analysis of studies, they are the measures the included studies report as showing significant improvement within the RMT groups. Adverse events were consistently not reported by the studies, with only one making specific reference to this (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>). </p> </section> <section id="CD006112-sec-0084"> <h3 class="title" id="CD006112-sec-0084">Overall completeness and applicability of evidence</h3> <p>Due to the life‐limiting nature of CF, the age of the participants recruited to studies in this population is of particular importance. Only half of the included studies stated the ages of participants (ranging from 6 to 25 years); five studies did not disclose details of participants' age except to state that four studies were in adults and one in children. With the current average life expectancy standing at around 49 years and the number of CF adults increasing (<a href="./references#CD006112-bbs2-0028" title="Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2019 Annual Data Report. www.cff.org/Research/Researcher-Resources/Patient-Registry/2019-Patient-Registry-Annual-Data-Report.pdf (accessed 16 December 2020).">CFF 2019</a>; <a href="./references#CD006112-bbs2-0053" title="Cystic Fibrosis Trust. UK Cystic Fibrosis Registry Annual Data Report 2019. www.cysticfibrosis.org.uk/the-work-we-do/uk-cf-registry/reporting-and-resources (accessed 16 December 2020).">UK CF Trust  2019</a>), the participants in these studies may not be representative of the diverse CF population. Studies specifically targetting paediatric or older adult participants would be beneficial.  </p> <p>Due to the progressive nature of CF, the pulmonary function of the participants could limit the effectiveness of RMT in comparison to a healthy population. Some of the included studies lack details in the clinical status and pulmonary function of participants, and some limited recruitment to those with higher lung functions (e.g. over 70% predicted FEV<sub>1</sub>) so this may limit the applicability of the evidence. With the recent introduction of CFTR modulator therapies the presentation of the CF population is changing, often with more stability in clinical outcomes (<a href="./references#CD006112-bbs2-0025" title="BellSC , MallMA , GutierrezH , MacekM , MadgeS , DaviesJC , et al. The future of cystic fibrosis care: a global perspective. The Lancet Respiratory Medicine2020;8(1):65-124.">Bell 2020</a>), which may also affect the applicability of these results in the future.  </p> <p>There is an apparent under‐use of assessing dyspnoea and exercise capacity following RMT which may limit the external validity of the research base. In healthy individuals, both an individual’s perception of breathlessness and their maximal exercise capacity has found to improve following RMT (<a href="./references#CD006112-bbs2-0036" title="El-ManshawiA , KillianKJ , SummersE , JonesN . Breathlessness during exercise with and without resistive loading. Journal of Applied Physiology1986;61(3):896-905.">El‐Manshawi 1986</a>; <a href="./references#CD006112-bbs2-0048" title="RomerLE , McConnellAK , JonesDD . Effects of inspiratory muscle training on time-trial performance in trained cyclists. Journal of Sports Sciences2002;29(97):547-62.">Romer 2002</a>). </p> </section> <section id="CD006112-sec-0085"> <h3 class="title" id="CD006112-sec-0085">Quality of the evidence</h3> <p>Overall, the methodological quality of the included studies was inconsistent and none addressed all aspects completely. A systematic review requires homogeneity between the included studies to allow firm conclusions to be drawn. Despite finding 10 studies which met the inclusion criteria of this review, the variation in their methodologies and outcomes was such that no combined analyses could be made. These differences occurred in all the major aspects of the studies including the outcomes employed, the units of measurement for certain outcomes and the method and extent to which the clinical status of the participants was established or reported. </p> <p>Following the GRADE assessments, we deemed the outcomes pulmonary function, exercise capacity, health‐related quality of life and postural stability and respiratory muscle function to have very low‐quality evidence (<a href="./full#CD006112-tbl-0001">summary of findings Table 1</a>). We downgraded the quality of the evidence due to the variations in resistance levels used across the studies, serious risks of bias (see below) and imprecision (small numbers of participants and numerical results not being available for some of the studies). </p> <p>The execution of the included studies (randomisation and blinding) ranged from being fully acknowledged, considered and reported to either being merely stated as "randomised to the two groups" or not being mentioned. The external validity (with particular regard to the participant demographics) was explicit in only five of the studies (<a href="./references#CD006112-bbs2-0004" title="BieliC , SelinaS , DemetI , AndreasJ , AlexanderM . Respiratory muscle endurance training in cystic fibrosis. European Respiratory Journal2014;44(Suppl 58):P1972. [CENTRAL: CN-01081092] [CFGD REGISTER: PE236b] [EMBASE: 71851116]BieliC , SummermatterS , BoutellierU , MoellerA . Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis. Pediatric Pulmonology2017;52(3):331-6. [CENTRAL: 1262285] [CFGD REGISTER: PE236a] [DOI: 10.1002/ppul.23647] [PMID: 28114723]">Bieli 2017</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). This aspect is of particular significance given that people who have CF are the target population. The nature of the disease means that two people of similar age, height and weight may have been affected by the condition differently and therefore may not "match" with regards to clinical status. </p> <p>Although all studies state that they randomised their participants to the treatment groups, only two studies indicated the method of allocation, one by stating that they employed the minimisation method (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>), the other reporting utilisation of pre‐filled envelopes specifying group allocations generated by a computer‐based programme (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). These studies were graded as having a low risk of bias, whereas the remaining eight studies were graded as having an unclear risk of bias. </p> <p>All the included studies were graded as having a high risk of performance bias, however studies are encouraged to specify more detail with regards to the training group. Although it may be difficult to blind the participants to which treatment arm they are randomised to, five studies made use of "sham" training for the control (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>; <a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>; <a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>). One study reported a blinded outcome assessor for all measurements (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>); two studies blinded the outcome assessors at the final data collection session (<a href="./references#CD006112-bbs2-0007" title="EnrightS , ChathamK , IonescuAA , ShaleDJ , UnnithanV . A randomised double blind controlled trial of inspiratory muscle training in cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine2000;161(3 Suppl):A753. [CFGD REGISTER: PE138a] EnrightS , ChathamK , IonescuAA , UnnithanVB , ShaleDJ . Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest2004;126(2):405-11. [CFGD REGISTER: PE138b] ">Enright 2004</a>; <a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>), whereas the majority of studies make no overt reference to any blinding. Out of the ten studies, none reported on all outcome measures thus suggesting a potential risk of bias. Two studies report withdrawals, but offer no explanation for these (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0005" title="ChathamK , IonescuA , DaviesC , BaldwinJ , EnrightS , ShaleDJ . Through range computer generated inspiratory muscle training in cystic fibrosis. Pediatric Pulmonology1997;24 Suppl 14:299. [ABSTRACT NO: 340] [CFGD REGISTER: PE90] ">Chatham 1997</a>). Overall, all of the included studies have been graded an unclear risk of bias as none provided sufficient information to arrive at a definitive conclusion. </p> </section> <section id="CD006112-sec-0086"> <h3 class="title" id="CD006112-sec-0086">Potential biases in the review process</h3> <p>We are not aware of any potential biases in the review process.</p> </section> <section id="CD006112-sec-0087"> <h3 class="title" id="CD006112-sec-0087">Agreements and disagreements with other studies or reviews</h3> <p>Overall, the current systematic review supports previous versions of this review and continues to highlight the need for more research in this area, specifically studies of high methodological quality. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006112-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: RMT (80% of maximal effort) versus control, Outcome 1: FEV1 (L)" data-id="CD006112-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: RMT (80% of maximal effort) versus control, Outcome 1: FEV<sub>1</sub> (L) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: RMT (80% of maximal effort) versus control, Outcome 2: FVC (L)" data-id="CD006112-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: RMT (80% of maximal effort) versus control, Outcome 2: FVC (L)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: RMT (80% of maximal effort) versus control, Outcome 3: Chronic Respiratory Disease Questionnaire (mastery)" data-id="CD006112-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: RMT (80% of maximal effort) versus control, Outcome 3: Chronic Respiratory Disease Questionnaire (mastery) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: RMT (80% of maximal effort) versus control, Outcome 4: Chronic Respiratory Disease Questionnaire (emotion)" data-id="CD006112-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: RMT (80% of maximal effort) versus control, Outcome 4: Chronic Respiratory Disease Questionnaire (emotion) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: RMT (60% of maximal effort) versus control, Outcome 1: FEV1 (L)" data-id="CD006112-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: RMT (60% of maximal effort) versus control, Outcome 1: FEV<sub>1</sub> (L) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: RMT (60% of maximal effort) versus control, Outcome 2: PImax (cm H₂O)" data-id="CD006112-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: RMT (60% of maximal effort) versus control, Outcome 2: PImax (cm H₂O)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: RMT (40% of maximal effort) versus control, Outcome 1: FEV1 (L)" data-id="CD006112-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: RMT (40% of maximal effort) versus control, Outcome 1: FEV<sub>1</sub> (L) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: RMT (40% of maximal effort) versus control, Outcome 2: FEV1 (% predicted)" data-id="CD006112-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: RMT (40% of maximal effort) versus control, Outcome 2: FEV<sub>1</sub> (% predicted) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: RMT (40% of maximal effort) versus control, Outcome 3: FVC (L)" data-id="CD006112-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: RMT (40% of maximal effort) versus control, Outcome 3: FVC (L)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: RMT (40% of maximal effort) versus control, Outcome 4: FVC (% predicted)" data-id="CD006112-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: RMT (40% of maximal effort) versus control, Outcome 4: FVC (% predicted)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: RMT (40% of maximal effort) versus control, Outcome 5: Inspiratory muscle endurance (% PImax)" data-id="CD006112-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: RMT (40% of maximal effort) versus control, Outcome 5: Inspiratory muscle endurance (% PImax) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 1: FEV1 (% predicted) absolute" data-id="CD006112-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 1: FEV<sub>1</sub> (% predicted) absolute </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 2: FEV1 (% predicted) change from baseline" data-id="CD006112-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 2: FEV<sub>1</sub> (% predicted) change from baseline </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 3: FVC (%) absolute" data-id="CD006112-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 3: FVC (%) absolute</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 4: FVC (%) change from baseline" data-id="CD006112-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 4: FVC (%) change from baseline </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 5: Peak expiratory flow (%) absolute" data-id="CD006112-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 5: Peak expiratory flow (%) absolute </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 6: Peak expiratory flow (%) change from baseline" data-id="CD006112-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 6: Peak expiratory flow (%) change from baseline </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 7: Six‐minute walk test absolute" data-id="CD006112-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 7: Six‐minute walk test absolute </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 8: Six‐minute walk test change from baseline" data-id="CD006112-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 8: Six‐minute walk test change from baseline </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 9: Maximal inspiratory pressure (PImax) absolute" data-id="CD006112-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 9: Maximal inspiratory pressure (PI<sub>max</sub>) absolute </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 10: Maximal inspiratory pressure (PImax) change from baseline" data-id="CD006112-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 10: Maximal inspiratory pressure (PI<sub>max</sub>) change from baseline </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 11: Maximal expiratory pressure (PEmax) absolute" data-id="CD006112-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 11: Maximal expiratory pressure (PE<sub>max)</sub> absolute </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 12: Maximal expiratory pressure (PEmax) change from baseline" data-id="CD006112-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 12: Maximal expiratory pressure (PE<sub>max)</sub> change from baseline </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 13: Adherence" data-id="CD006112-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 13: Adherence</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 14: Resting oxygen saturations absolute" data-id="CD006112-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.14</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 14: Resting oxygen saturations absolute </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 15: Resting oxygen saturations change from baseline" data-id="CD006112-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.15</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 15: Resting oxygen saturations change from baseline </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 16: Oxygen saturation change during test (absolute)" data-id="CD006112-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.16</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 16: Oxygen saturation change during test (absolute) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 17: Oxygen saturation change during test (change from baseline)" data-id="CD006112-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.17</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 17: Oxygen saturation change during test (change from baseline) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 18: Postural stability test absolute values after treatment (8 weeks)" data-id="CD006112-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.18</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 18: Postural stability test absolute values after treatment (8 weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 19: Postural stability test change from baseline (8 weeks)" data-id="CD006112-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.19</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 19: Postural stability test change from baseline (8 weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 20: Limits of stability test absolute values after treatment (8 weeks)" data-id="CD006112-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.20</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 20: Limits of stability test absolute values after treatment (8 weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-004.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: RMT (30% of maximal effort) versus control, Outcome 21: Limits of stability test change from baseline (8 weeks)" data-id="CD006112-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-004.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.21</div> <div class="figure-caption"> <p>Comparison 4: RMT (30% of maximal effort) versus control, Outcome 21: Limits of stability test change from baseline (8 weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-004.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: RMT (20% of maximal effort) versus control, Outcome 1: FEV1 (L)" data-id="CD006112-fig-0033" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: RMT (20% of maximal effort) versus control, Outcome 1: FEV<sub>1</sub> (L) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006112-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/urn:x-wiley:14651858:media:CD006112:CD006112-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: RMT (20% of maximal effort) versus control, Outcome 2: FVC (L)" data-id="CD006112-fig-0034" src="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_t/tCD006112-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: RMT (20% of maximal effort) versus control, Outcome 2: FVC (L)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/media/CDSR/CD006112/image_n/nCD006112-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006112-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: respiratory muscle training compared with control for cystic fibrosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Respiratory muscle training compared with control for cystic fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults and children with cystic fibrosis </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> respiratory muscle training<sup>a</sup> </p> <p><b>Comparison:</b> control<sup>a</sup> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Respiratory muscle training</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FEV<sub>1</sub> % predicted</b> </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No study reported any differences between the respiratory muscle training group and the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> <p>(4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported data for FEV<sub>1</sub> % predicted at 40% of maximal capacity (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>). 2 studies reported FEV<sub>1</sub> % predicted at 30% of maximal capacity (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). 1 study reported FEV<sub>1</sub> % predicted, but did not specify the resistance used (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). </p> <p>3 studies reported FEV<sub>1</sub> measured in L and 1 measured z score; 1 study did not report the units of measurement. Results were similar to those for FEV<sub>1</sub> % predicted. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FVC: % predicted</b> </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No study reported any differences between the respiratory muscle training group and the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> <p>(3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported data for analysis for FVC (% predicted) at 40% of maximal capacity (<a href="./references#CD006112-bbs2-0006" title="deJongW , vanAalderenWM , KraanJ , KoeterGH , van derSchansCP . Inspiratory muscle training in patients with cystic fibrosis. Respiratory medicine2001;95(1):31-36. [CFGD REGISTER: PE130] ">de Jong 2001</a>) and two studies at 30% of maximal capacity (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). </p> <p>2 studies reported FVC in L and 1 measured z score; 1 study did not report the units of measurement. Results were similar to those for FVC % predicted. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exercise capacity:</b> VO<sub>2max</sub> (mL/kg/min) </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No study reported any differences between the respiratory muscle training group and the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> <p>(3 studies including 1 cross‐over study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One study with an unspecified level of resistance reported an improvement within the respiratory muscle training group. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HRQoL:</b> total score </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>2 studies reported no differences between the respiratory muscle training group and the control group. </p> <p>1 study reported improvements in the parameters of mastery and emotion in the respiratory muscle training group compared to the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69</p> <p>(3 studies including 1 cross‐over study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 studies used the Chronic Respiratory Disease Questionnaire (CRDQ) and 1 study used the cystic fibrosis questionnaire (CFQ). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Respiratory muscle function:</b> maximal inspiratory pressure (PI<sub>max</sub>) </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>There was a greater improvement in the respiratory muscle training groups in 2 of the 4 studies measuring this outcome: MD 26.00 (95% CI 8.63 to 43.47) (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>); and MD 14.63 (95% CI 5.63 to 23.63) (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). </p> <p>The remaining 2 studies reported no differences between the respiratory muscle training group and the control group (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>; <a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> <p>(4 studies including 1 cross‐over study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Of the studies reporting a difference, the Sawyer study measured at 60% of maximal effort (<a href="./references#CD006112-bbs2-0009" title="SawyerEH , ClantonTL . Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest1993;104(5):1490-7. [CFGD REGISTER: PE170] ">Sawyer 1993</a>) and the Zeren study measured at 30% resistance (<a href="./references#CD006112-bbs2-0010" title="NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03375684 (first posted 18 December 2017). ZerenM , CakirE , GursesHN . Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine2019;148:24-30. [CFGD REGISTER: PE275] [DOI: 10.1016/j.rmed.2019.01.013]">Zeren 2019</a>). </p> <p>1 of the remaining studies reported at 30% of maximal effort (<a href="./references#CD006112-bbs2-0002" title="AmelinaE , CherniakA , ChikinaS , KrasovskyS , AppaevaA . Inspiratory muscle training (IMT) in cystic fibrosis adults. In: European Respiratory Society Annual Congress, Sep 2-6; Munich, Germany. 2006:716s. [ABSTRACT NO: P4112] [CFGD REGISTER: PE177a] CherniakA , AmelinaE , KrasovskyS , NekludovaG , ChikinaS . The effect of high intensity inspiratory muscle training in adults with cystic fibrosis (CF). European Respiratory Journal2007;30(Suppl 51):767s. [ABSTRACT NO: E4514] [CENTRAL: 645383] [CFGD REGISTER: PE177b] ">Amelina 2006</a>) and 1 did not specify the level of resistance (<a href="./references#CD006112-bbs2-0003" title="AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. American Review of Respiratory Disease1982;126(5):855-9. [CFGD REGISTER: PE127b] AsherMI , PardyRL , CoatesAL , ThomasE , MacklemPT . The effects of inspiratory muscle training in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine (Annual Clinical and Scientific meeting for New Zealand Fellows and Advanced Trainees)1983;13:204. [CFGD REGISTER: PE127a] ">Asher 1983</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Respiratory muscle function</b>: inspiratory capacity </p> <p>Follow‐up: 1 ‐ 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>FEV<sub>1</sub> </b> : forced expiratory volume in 1 second; <b>FVC</b> : forced vital capacity; <b>HRQoL</b> : health related quality of life; <b>NA</b> : not applicable; <b>VO₂<sub>max</sub> </b> : maximal oxygen uptake. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>a. The resistance level of the respiratory muscle training intervention was variable; three studies used 80% of maximal effort, one study used 60% of maximal effort, one study used 40% of maximal effort, one study used 30% of maximal effort and three studies did not specify the level of resistance. Control groups were also variable; cycle ergometer, H<sub>2</sub>0, treatment as usual, standard chest physiotherapy, low resistance threshold loading device, no training or sham training. </p> <p>b. Downgraded twice due to serious risk of bias: the included studies lacked methodological detail relating to methods of randomisation, allocation concealment and blinding. Most of the studies were at high risk of bias due to lack of blinding, incomplete outcome data or selective reporting, or both. </p> <p>c. Downgraded due to imprecision: studies included a small number of participants and numerical results were not available for some of the studies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: respiratory muscle training compared with control for cystic fibrosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/full#CD006112-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006112-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">RMT (80% of maximal effort) versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 FEV<sub>1</sub> (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 FVC (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Chronic Respiratory Disease Questionnaire (mastery) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Chronic Respiratory Disease Questionnaire (emotion) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">RMT (80% of maximal effort) versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006112-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">RMT (60% of maximal effort) versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 FEV<sub>1</sub> (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 PImax (cm H₂O) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">RMT (60% of maximal effort) versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006112-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">RMT (40% of maximal effort) versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 FEV<sub>1</sub> (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 FEV<sub>1</sub> (% predicted) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 FVC (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 FVC (% predicted) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Inspiratory muscle endurance (% PImax) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">RMT (40% of maximal effort) versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006112-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">RMT (30% of maximal effort) versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 FEV<sub>1</sub> (% predicted) absolute <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 FEV<sub>1</sub> (% predicted) change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 FVC (%) absolute <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 FVC (%) change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Peak expiratory flow (%) absolute <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.6 Peak expiratory flow (%) change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.7 Six‐minute walk test absolute <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.8 Six‐minute walk test change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.9 Maximal inspiratory pressure (PI<sub>max</sub>) absolute <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.9.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.10 Maximal inspiratory pressure (PI<sub>max</sub>) change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.10.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.11 Maximal expiratory pressure (PE<sub>max)</sub> absolute <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.11.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.12 Maximal expiratory pressure (PE<sub>max)</sub> change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.12.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.13 Adherence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.13.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.14 Resting oxygen saturations absolute <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.14.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.15 Resting oxygen saturations change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.15.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.16 Oxygen saturation change during test (absolute) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.16.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.17 Oxygen saturation change during test (change from baseline) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.17.1 Two to six months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.18 Postural stability test absolute values after treatment (8 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.18.1 Overall score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.18.2 Anterior/posterior SI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.18.3 Medial/lateral SI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.19 Postural stability test change from baseline (8 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.19.1 Overall score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.19.2 Anterior/posterior SI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.19.3 Medial/lateral SI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.20 Limits of stability test absolute values after treatment (8 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.20.1 Overall score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.20.2 Forward DS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.20.3 Backward DS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.20.4 Left DS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.20.5 Right DS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.21 Limits of stability test change from baseline (8 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.21.1 Overall score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.21.2 Forward DS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.21.3 Backward DS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.21.4 Left DS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.21.5 Right DS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">RMT (30% of maximal effort) versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006112-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">RMT (20% of maximal effort) versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 FEV<sub>1</sub> (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 FVC (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 One to three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">RMT (20% of maximal effort) versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006112.pub5/references#CD006112-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006112.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006112-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006112-note-0011">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006112-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006112-note-0009">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD006112-note-0006">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD006112-note-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD006112-note-0010">Polski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006112\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006112\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006112\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006112\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006112\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006112.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006112.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006112.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006112.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006112.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726577034"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006112.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726577038"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006112.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e9707881cf3c9',t:'MTc0MDcyNjU3Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 